10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 31, 2023

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from           to         

Commission file number   0-7977

____________________________________________________

NORDSON CORPORATION

(Exact name of registrant as specified in its charter)

___________________________________________________

Ohio

(State or other jurisdiction of incorporation or organization)

28601 Clemens Road

Westlake, Ohio

(Address of principal executive offices)

34-0590250

(I.R.S. Employer Identification No.)

44145

(Zip Code)

(440) 892-1580

(Registrant's Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange On Which Registered
Common Shares, without par value	NDSN	Nasdaq Stock Market LLC

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).    Yes  x    No  o

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  x

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:  Common Shares, without par value as of August 22, 2023:  57,014,497

Table of Contents

PART I – FINANCIAL INFORMATION	3
ITEM 1.  FINANCIAL STATEMENTS (UNAUDITED)	3
Condensed Consolidated Statements of Income	3
Consolidated Statements of Comprehensive Income	4
Consolidated Balance Sheets	5
Consolidated Statements of Shareholders' Equity	6
Condensed Consolidated Statements of Cash Flows	8
Notes to Condensed Consolidated Financial Statements	9
ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	24
Overview	24
Critical Accounting Policies and Estimates	24
Results of Operations	25
Financial Condition	28
ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	29
ITEM 4.  CONTROLS AND PROCEDURES	29
PART II – OTHER INFORMATION	30
ITEM 1.  LEGAL PROCEEDINGS	30
ITEM 1A.  RISK FACTORS	30
ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	30
ITEM 5. OTHER INFORMATION	30
ITEM 6.  EXHIBITS	31
SIGNATURE	32

Page 2

Nordson Corporation

Part I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

Condensed Consolidated Statements of Income

	Three Months Ended				Nine Months Ended
(In thousands, except for per share data)	July 31, 2023		July 31, 2022		July 31, 2023		July 31, 2022
Sales	$	648,677	$	662,128	$	1,909,319	$	1,906,697
Operating costs and expenses:
Cost of sales	288,357		296,544		868,007		843,344
Selling and administrative expenses	189,324		180,666		553,590		538,602
	477,681		477,210		1,421,597		1,381,946
Operating profit	170,996		184,918		487,722		524,751
Other income (expense):
Interest expense	(12,089)		(5,737)		(32,532)		(16,748)
Interest and investment income	603		572		1,628		1,456
Other income (expense)- net	2,542		752		(2,059)		(37,720)
	(8,944)		(4,413)		(32,963)		(53,012)
Income before income taxes	162,052		180,505		454,759		471,739
Income taxes	34,161		38,694		95,044		99,885
Net income	$	127,891	$	141,811	$	359,715	$	371,854
Average common shares	56,989		57,409		57,114		57,782
Incremental common shares attributable to equity compensation	541		560		543		610
Average common shares and common share equivalents	57,530		57,969		57,657		58,392
Basic earnings per share	$	2.24	$	2.47	$	6.30	$	6.44
Diluted earnings per share	$	2.22	$	2.45	$	6.24	$	6.37

See accompanying notes.

Page 3

Nordson Corporation

Consolidated Statements of Comprehensive Income

	Three Months Ended				Nine Months Ended
(In thousands)	July 31, 2023		July 31, 2022		July 31, 2023		July 31, 2022
Net income	$	127,891	$	141,811	$	359,715	$	371,854
Components of other comprehensive income (loss):
Foreign currency translation adjustments	3,455		(21,220)		79,986		(81,479)
Pension settlement adjustment, net of tax	—		—		—		32,047
Pension and other postretirement plan adjustments, net of tax	(159)		1,848		(908)		7,686
Total other comprehensive income (loss)	3,296		(19,372)		79,078		(41,746)
Total comprehensive income	$	131,187	$	122,439	$	438,793	$	330,108

See accompanying notes.

Page 4

Nordson Corporation

Consolidated Balance Sheets

(In thousands)
Assets
Current assets:	July 31, 2023		October 31, 2022
Cash and cash equivalents	$	143,138	$	163,457
Receivables - net	533,793		537,313
Inventories - net	439,741		383,398
Prepaid expenses and other current assets	60,249		48,803
Total current assets	1,176,921		1,132,971
Goodwill	2,110,780		1,804,693
Intangible assets - net	350,524		329,402
Property, plant and equipment - net	350,735		353,442
Operating right of use lease assets	104,592		102,279
Deferred income taxes	12,199		10,447
Other assets	91,281		87,141
Total assets	$	4,197,032	$	3,820,375
Liabilities and shareholders' equity
Current liabilities:
Current maturities of long-term debt and notes payable	$	110,643	$	392,537
Accrued liabilities	169,635		206,828
Accounts payable	105,075		99,276
Customer advanced payments	95,274		92,584
Income taxes payable	26,661		22,333
Operating lease liability - current	16,809		15,738
Finance lease liability - current	4,512		4,907
Total current liabilities	528,609		834,203
Long-term debt	727,455		345,320
Operating lease liability - noncurrent	91,287		90,768
Deferred income taxes	119,734		110,781
Postretirement obligations	57,528		56,804
Pension obligations	46,782		40,551
Finance lease liability - noncurrent	10,507		11,184
Other long-term liabilities	35,324		36,389
Shareholders' equity:
Common shares	12,253		12,253
Capital in excess of stated value	660,218		626,697
Retained earnings	3,900,384		3,652,216
Accumulated other comprehensive loss	(128,704)		(207,782)
Common shares in treasury, at cost	(1,864,345)		(1,789,009)
Total shareholders' equity	2,579,806		2,294,375
Total liabilities and shareholders' equity	$	4,197,032	$	3,820,375

See accompanying notes.

Page 5

Nordson Corporation

Consolidated Statements of Shareholders’ Equity

	Nine Months Ended July 31, 2023
(In thousands, except for share and per share data)	Common Shares		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Common Shares in Treasury, at cost		TOTAL
November 1, 2022	$	12,253	$	626,697	$	3,652,216	$	(207,782)	$	(1,789,009)	$	2,294,375
Shares issued under company stock and employee benefit plans	—		7,032		—		—		1,775		8,807
Stock-based compensation	—		7,071		—		—		—		7,071
Purchase of treasury shares	—		—		—		—		(6,875)		(6,875)
Dividends declared ($0.65 per share)	—		—		(37,199)		—		—		(37,199)
Net income	—		—		104,261		—		—		104,261
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	—		—		—		76,821		—		76,821
Defined benefit pension and post-retirement plan adjustments	—		—		—		(576)		—		(576)
January 31, 2023	$	12,253	$	640,800	$	3,719,278	$	(131,537)	$	(1,794,109)	$	2,446,685
Shares issued under company stock and employee benefit plans	—		2,632		—		—		369		3,001
Stock-based compensation	—		4,970		—		—		—		4,970
Purchase of treasury shares	—		—		—		—		(47,490)		(47,490)
Dividends declared ($0.65 per share)	—		—		(37,264)		—		—		(37,264)
Net income	—		—		127,563		—		—		127,563
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	—		—		—		(290)		—		(290)
Defined benefit pension and post-retirement plan adjustments	—		—		—		(173)		—		(173)
April 30, 2023	$	12,253	$	648,402	$	3,809,577	$	(132,000)	$	(1,841,230)	$	2,497,002
Shares issued under company stock and employee benefit plans	—		5,958		—		—		683		6,641
Stock-based compensation	—		5,858		—		—		—		5,858
Purchase of treasury shares	—		—		—		—		(23,798)		(23,798)
Dividends declared ($0.65 per share)	—		—		(37,084)		—		—		(37,084)
Net income	—		—		127,891		—		—		127,891
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	—		—		—		3,455		—		3,455
Defined benefit pension and post-retirement plan adjustments	—		—		—		(159)		—		(159)
July 31, 2023	$	12,253	$	660,218	$	3,900,384	$	(128,704)	$	(1,864,345)	$	2,579,806

Page 6

Nordson Corporation

Consolidated Statements of Shareholders’ Equity

	Nine Months Ended July 31, 2022
(In thousands, except for share and per share data)	Common Shares		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Common Shares in Treasury, at cost		TOTAL
November 1, 2021	$	12,253	$	585,334	$	3,265,027	$	(175,835)	$	(1,527,649)	$	2,159,130
Shares issued under company stock and employee benefit plans	—		5,046		—		—		675		5,721
Stock-based compensation	—		8,392		—		—		—		8,392
Purchase of treasury shares	—		—		—		—		(35,002)		(35,002)
Dividends declared ($0.51 per share)	—		—		(29,724)		—		—		(29,724)
Net income	—		—		120,409		—		—		120,409
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	—		—		—		(13,358)		—		(13,358)
Defined benefit pension and post-retirement plan adjustments	—		—		—		3,060		—		3,060
January 31, 2022	$	12,253	$	598,772	$	3,355,712	$	(186,133)	$	(1,561,976)	$	2,218,628
Shares issued under company stock and employee benefit plans	—		1,843		—		—		234		2,077
Stock-based compensation	—		7,394		—		—		—		7,394
Purchase of treasury shares	—		—		—		—		(105,464)		(105,464)
Dividends declared ($0.51 per share)	—		—		(29,577)		—		—		(29,577)
Net income	—		—		109,634		—		—		109,634
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	—		—		—		(46,901)		—		(46,901)
Pension plan settlement adjustment	—		—		—		32,047		—		32,047
Defined benefit pension and post-retirement plan adjustments	—		—		—		2,778		—		2,778
April 30, 2022	$	12,253	$	608,009	$	3,435,769	$	(198,209)	$	(1,667,206)	$	2,190,616
Shares issued under company stock and employee benefit plans	—		940		—		—		107		1,047
Stock-based compensation	—		7,618		—		—		—		7,618
Purchase of treasury shares	—		—		—		—		(93,301)		(93,301)
Dividends declared ($0.51 per share)	—		—		(29,374)		—		—		(29,374)
Net income	—		—		141,811		—		—		141,811
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	—		—		—		(21,220)		—		(21,220)
Defined benefit pension and post-retirement plan adjustments	—		—		—		1,848		—		1,848
July 31, 2022	$	12,253	$	616,567	$	3,548,206	$	(217,581)	$	(1,760,400)	$	2,199,045

See accompanying notes.

Page 7

Nordson Corporation

Condensed Consolidated Statements of Cash Flows

(In thousands)	Nine Months Ended
Cash flows from operating activities:	July 31, 2023		July 31, 2022
Net income	$	359,715	$	371,854
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	80,637		75,242
Non-cash stock compensation	17,067		23,404
Deferred income taxes	(930)		(11,094)
Other non-cash expense	762		43,325
Loss on sale of property, plant and equipment	1,624		(707)
Changes in operating assets and liabilities	19,197		(162,333)
Net cash provided by operating activities	478,072		339,691
Cash flows from investing activities:
Additions to property, plant and equipment	(24,244)		(39,373)
Proceeds from sale of property, plant and equipment	91		415
Acquisition of business, net of cash acquired	(377,843)		(171,613)
Net cash used in investing activities	(401,996)		(210,571)
Cash flows from financing activities:
Proceeds from long-term debt	1,279,151		63,067
Repayment of long-term debt	(1,205,195)		(40,162)
Repayment of finance lease obligations	(4,769)		(3,726)
Issuance of common shares	18,449		8,845
Purchase of treasury shares	(78,163)		(233,767)
Dividends paid	(111,547)		(88,675)
Net cash used in financing activities	(102,074)		(294,418)
Effect of exchange rate changes on cash	5,679		(5,937)
Decrease in cash and cash equivalents	(20,319)		(171,235)
Cash and cash equivalents at beginning of period	163,457		299,972
Cash and cash equivalents at end of period	$	143,138	$	128,737

See accompanying notes.

Page 8

Nordson Corporation

Notes to Condensed Consolidated Financial Statements

July 31, 2023

NOTE REGARDING AMOUNTS AND FISCAL YEAR REFERENCES

In this quarterly report, all amounts related to United States dollars and foreign currency and to the number of Nordson Corporation’s common shares, except for per share earnings and dividend amounts, are expressed in thousands. Unless the context otherwise indicates, all references to “we” or the “Company” mean Nordson Corporation.

Unless otherwise noted, all references to years relate to our fiscal year ending October 31.

Significant accounting policies

Basis of presentation.  The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles in the United States (U.S. GAAP) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine months ended July 31, 2023 are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the Consolidated Financial Statements and notes included in our Annual Report on Form 10-K for the year ended October 31, 2022.

Consolidation.  The Condensed Consolidated Financial Statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50% or less or in which we do not have control but have the ability to exercise significant influence, are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.  

Use of estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements.  Actual amounts could differ from these estimates.

Revenue recognition. A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. Revenue for undelivered items is deferred and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of July 31, 2023 and 2022 were not material.

However, for certain contracts related to the sale of customer-specific products within our Medical and Fluid Solutions segment, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled and we are contractually entitled to payment for work performed to date plus a reasonable margin.  

As control transfers over time, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material on July 31, 2023 and October 31, 2022. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues at July 31, 2023 and October 31, 2022.

Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services.  Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred as the amortization period resulting from capitalizing the

Page 9

Nordson Corporation

costs is one year or less. These costs are recorded within Selling and administrative expenses in our Condensed Consolidated Statements of Income.

We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and are not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and, therefore, these items are typically regarded as inconsequential or not material.

We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to our Operating segments Note for details.

Earnings per share.  Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted shares and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options excluded from the calculation of diluted earnings per share for the three months ended July 31, 2023 and 2022 were 138 and 76, respectively. Options excluded from the calculation of diluted earnings per share for the nine months ended July 31, 2023 and 2022 were 141 and 79, respectively.

Recently issued accounting standards

There have been no new accounting standards issued which would require either disclosure or adoption during the current periods.

Acquisitions

Business acquisitions have been accounted for using the acquisition method, with the acquired assets and liabilities recorded at estimated fair value on the dates of acquisition. The cost in excess of the net assets of the business acquired is included in goodwill. Operating results since the respective dates of acquisitions are included in the Condensed Consolidated Statements of Income.

2023 Acquisitions

On August 24, 2023, the Company completed the acquisition of the ARAG Group and its subsidiaries (ARAG Group or ARAG) pursuant to the terms of the Sale and Purchase Agreement, dated as of June 25, 2023, by and among the Company, its Italian subsidiary, Capvis Equity V LP (Capvis), DRIP Co-Investment (DRIP), and certain individuals (the Individual Sellers, and together with Capvis and DRIP, collectively, the Sellers). ARAG is a global market and innovation leader in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. ARAG will operate as a division of our Industrial Precision Solutions segment. In anticipation of the acquisition, the Company entered into a €760,000 senior unsecured term loan facility with a group of banks in August 2023 (the Term Facility). The Term Facility has a 364-day term and matures in August 2024, and loans under the facility bear interest at a eurocurrency rate plus an applicable margin that will range from 1.1250% to 1.625% based on the Company’s Leverage Ratio (as defined in the term loan credit agreement and calculated on a consolidated net debt basis). The all-cash ARAG acquisition of approximately €957,000, net of the repayment of approximately €30,300 of debt of the acquired companies, was funded using the Term Facility and Revolving Facility. The financial results of the ARAG Group acquisition are not expected to have a material impact on our Consolidated Financial Statements.

On November 3, 2022, we acquired 100% of CyberOptics Corporation (CyberOptics). CyberOptics is a leading global developer and manufacturer of high-precision 3D optical sensing technology solutions. The CyberOptics acquisition expanded our test and inspection platform, providing differentiated technology that expands our product offering in the semiconductor and electronics industries and is reported in our Advanced Technology Solutions segment. We acquired CyberOptics for an aggregate purchase price of $377,843, net of cash of approximately $40,890, funded using borrowings under our revolving credit facility and cash on hand. Based on the fair value of the assets acquired and the liabilities assumed, goodwill of $279,630 and identifiable intangible assets of $58,600 were recorded. The identifiable intangible assets consist primarily of $15,200 of tradenames (amortized over fifteen years), $14,600 of technology (amortized over seven years), and $28,800 of customer contracts (amortized over twelve years). The results of CyberOptics are not material to our Consolidated Financial Statements. As of July 31, 2023, the purchase price allocation remains preliminary as we complete our assessment of intangibles and income taxes.

Page 10

Nordson Corporation

The assets and liabilities acquired were as follows:

	November 3, 2022
Cash	$	40,890
Receivables - net	21,364
Inventories - net	35,300
Goodwill	279,630
Intangibles	58,600
Other assets	14,046
Total Assets	$	449,830
Accounts payable	$	8,109
Deferred income taxes	14,294
Other liabilities	8,694
Total Liabilities	$	31,097

2022 Acquisition

On November 1, 2021, we acquired 100% of NDC Technologies (NDC), a leading global provider of precision measurement solutions for in-line manufacturing process control. NDC's technology portfolio includes in-line measurement sensors, gauges and analyzers using near-infrared, laser, X-ray, optical and nucleonic technologies, as well as proprietary algorithms and software. We acquired NDC for an aggregate purchase price of $171,613, net of cash of approximately $7,533 and other working capital adjustments of $2,763, utilizing cash on hand. Based on the fair value of the assets acquired and the liabilities assumed, goodwill of $131,129 and identifiable intangible assets of $31,130 were recorded. The identifiable intangible assets consist primarily of $10,800 of tradenames (amortized over thirteen years), $10,000 of technology (amortized over seven years), $9,500 of customer relationships (amortized over four years) and $830 of non-compete agreements (amortized over three years). Goodwill associated with this acquisition of $72,018 is tax deductible. This acquisition is being reported in our Industrial Precision Solutions segment and the results of NDC are not material to our Consolidated Financial Statements.

Receivables

Our allowance for credit losses is principally determined based on aging of receivables. Receivables are exposed to credit risk based on the customers' ability to pay which is influenced by, among other factors, their financial liquidity. We perform ongoing customer credit evaluation to maintain sufficient allowances for potential credit losses. Our segments perform credit evaluation and monitoring to estimate and manage credit risk through the review of customer information, credit ratings, approval and monitoring of customer credit limits, and assessment of market conditions. We may also require prepayments or bank guarantees from customers to mitigate credit risk. Our receivables are generally short-term in nature with a majority of receivables outstanding less than 90 days. Accounts receivable balances are written-off against the allowance if deemed uncollectible.

Accounts receivable are net of an allowance for credit losses of $8,076 and $8,218 on July 31, 2023 and October 31, 2022, respectively. Provision losses related to allowance for credit losses of $410 and provision income of $239 was recorded for the three and nine months ended July 31, 2023, respectively, compared to provision expense of $788 and $1,439 for the same periods a year ago, respectively. The remaining change in the allowance for credit losses is principally related to net write-off/recoveries of uncollectible accounts as well as currency translation.

Inventories

Components of inventories were as follows:

	July 31, 2023		October 31, 2022
Finished goods	$	234,690	$	218,491
Raw materials and component parts	200,475		157,447
Work-in-process	62,856		53,195
	498,021		429,133
Obsolescence and other reserves	(58,280)		(45,735)
	$	439,741	$	383,398

See Acquisitions Note for inventory increase attributable to acquisition of CyberOptics.

Page 11

Nordson Corporation                                    

Property, Plant and Equipment

Components of property, plant and equipment were as follows:

	July 31, 2023		October 31, 2022
Land	$	9,856	$	9,278
Land improvements	5,033		4,979
Buildings	282,260		271,450
Machinery and equipment	536,215		505,343
Enterprise management system	52,938		52,513
Construction-in-progress	20,130		31,466
Leased property under finance leases	28,047		27,512
	934,479		902,541
Accumulated depreciation and amortization	(583,744)		(549,099)
	$	350,735	$	353,442

Depreciation expense was $13,180 and $12,178 for the three months ended July 31, 2023 and 2022, respectively. Depreciation expense was $38,798 and $36,876 for the nine months ended July 31, 2023 and 2022, respectively.

Goodwill and other intangible assets  

Changes in the carrying amount of goodwill for the nine months ended July 31, 2023 by operating segment were as follows:

	Industrial Precision Solutions		Medical Fluid Systems		Advanced Technology Solutions		Total
Balance at October 31, 2022	$	520,236	$	1,172,069	$	112,388	$	1,804,693
Acquisitions	—		—		279,630		279,630
Currency effect	4,744		3,869		17,844		26,457
Balance at July 31, 2023	$	524,980	$	1,175,938	$	409,862	$	2,110,780

The increase in goodwill for the nine months ended July 31, 2023 was due to the acquisition of CyberOptics. See Acquisitions Note for additional details.

Page 12

Nordson Corporation

Information regarding our intangible assets subject to amortization was as follows:

	July 31, 2023
	Carrying  Amount		Accumulated Amortization		Net Book  Value
Customer relationships	$	517,147	$	282,598	$	234,549
Patent/technology costs	176,396		109,783		66,613
Trade name	99,413		50,673		48,740
Non-compete agreements	10,559		9,937		622
Other	143		143		—
Total	$	803,658	$	453,134	$	350,524
	October 31, 2022
	Carrying  Amount		Accumulated Amortization		Net Book  Value
Customer relationships	$	480,058	$	250,798	$	229,260
Patent/technology costs	157,549		96,426		61,123
Trade name	82,759		44,707		38,052
Non-compete agreements	10,253		9,290		963
Other	446		442		4
Total	$	731,065	$	401,663	$	329,402

Amortization expense for the three months ended July 31, 2023 and 2022 was $13,922 and $12,709, respectively. Amortization expense for the nine months ended July 31, 2023 and 2022 was $41,839 and $38,366, respectively. See Acquisitions Note for details regarding intangibles recorded due to the acquisition of CyberOptics.

Pension and other postretirement plans

During the second quarter of 2022, we completed a partial plan settlement transaction in regards to two of our U.S. pension plans in which plan assets amounting to $171,181 were used to purchase a group annuity contract from The Prudential Insurance Company of America (Prudential). The settlement resulted in a loss of $41,221, which is included in Other-net on the Condensed Consolidated Statements of Income. This transaction relieved the Company of its responsibility for the pension obligation related to certain retired employees and transferred the obligation and payment responsibility to Prudential for retirement benefits owed to approximately 1,500 retirees and other beneficiaries. The annuity contract covered retirees who commenced receiving benefits on or before November 1, 2021. The monthly retirement benefit payment amounts currently received by retirees and their beneficiaries did not change as a result of this transaction. Plan participants not included in the transaction remain in the plans and responsibility for payment of the retirement benefits remains with the Company.

Page 13

Nordson Corporation

The components of net periodic pension and other postretirement cost for the three and nine months ended July 31, 2023 and 2022 were:

	U.S.				International
Three Months Ended	2023		2022		2023		2022
Service cost	$	2,744	$	3,423	$	281	$	423
Interest cost	4,176		3,322		642		272
Expected return on plan assets	(6,529)		(5,692)		(392)		(347)
Amortization of prior service cost (credit)	—		12		(13)		(13)
Amortization of net actuarial loss	—		1,197		20		558
Total benefit cost	$	391	$	2,262	$	538	$	893
	U.S.				International
Nine Months Ended	2023		2022		2023		2022
Service cost	$	8,233	$	13,338	$	838	$	1,343
Interest cost	12,526		11,146		1,887		861
Expected return on plan assets	(19,587)		(22,082)		(1,151)		(1,109)
Amortization of prior service cost (credit)	—		36		(38)		(43)
Amortization of net actuarial loss	—		6,282		61		1,758
Settlement loss	—		41,221		—		—
Total benefit cost	$	1,172	$	49,941	$	1,597	$	2,810

The components of other postretirement benefit costs for the three and nine months ended July 31, 2023 and 2022 were:

	U.S.				International
Three Months Ended	2023		2022		2023		2022
Service cost	$	100	$	172	$	1	$	3
Interest cost	766		481		3		3
Amortization of net actuarial (gain) loss	—		244		(16)		(12)
Total benefit cost (income)	$	866	$	897	$	(12)	$	(6)
	U.S.				International
Nine Months Ended	2023		2022		2023		2022
Service cost	$	299	$	515	$	4	$	9
Interest cost	2,297		1,443		8		10
Amortization of net actuarial (gain) loss	—		733		(47)		(37)
Total benefit cost (income)	$	2,596	$	2,691	$	(35)	$	(18)

The components of net periodic pension and other postretirement cost other than service cost are included in Other – net in our Condensed Consolidated Statements of Income.

Income taxes

We record our interim provision for income taxes based on our estimated annual effective tax rate, as well as certain items discrete to the current periods. The effective tax rate for the three months ended July 31, 2023 and 2022 was 21.1% and 21.4%, respectively. The effective tax rate for the nine months ended July 31, 2023 and 2022 was 20.9% and 21.2%, respectively.

Due to our share-based payment transactions, our income tax provision included a discrete tax benefit of $996 and $2,745 for the three months and nine months ended July 31, 2023, respectively, compared to $115 and $1,539 for the three and nine months ended July 31, 2022, respectively.

Page 14

Nordson Corporation

Accumulated other comprehensive income (loss)

The components of accumulated other comprehensive income (loss), including adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below.

	Cumulative translation adjustments		Pension and postretirement  benefit plan adjustments		Accumulated other  comprehensive income (loss)
Balance at October 31, 2022	$	(160,046)	$	(47,736)	$	(207,782)
Pension and other postretirement plan adjustments, net of tax of ($305)	—		(908)		(908)
Foreign currency translation adjustments (a)	79,986		—		79,986
Balance at July 31, 2023	$	(80,060)	$	(48,644)	$	(128,704)

(a) Includes a net loss of $3,672, net of tax of $1,097, on net investment hedges.

Stock-based compensation

During the 2021 Annual Meeting of Shareholders, our shareholders approved the Nordson Corporation 2021 Stock Incentive and Award Plan (the 2021 Plan) as the successor to the Amended and Restated 2012 Stock Incentive and Award Plan (the 2012 Plan). The 2021 Plan provides for the granting of stock options, stock appreciation rights, restricted shares, restricted share units, performance shares, cash awards and other stock or performance-based incentives. A maximum of 900 common shares were authorized for grant under the 2021 Plan plus the number of shares that remained available to be granted under the 2012 Plan, as well as issuable under the CyberOptics equity plan. As of July 31, 2023, a total of 2,012 common shares were available to be granted under the 2021 Plan.

Stock Options

Nonqualified or incentive stock options may be granted to our employees and directors. Generally, options granted to employees may be exercised beginning one year from the date of grant at a rate not exceeding 25% per year and expire 10 years from the date of grant. Vesting accelerates upon a qualified termination in connection with a change in control. In the event of termination of employment due to early retirement or normal retirement at age 65, options granted within 12 months prior to termination are forfeited, and vesting continues post retirement for all other unvested options granted. In the event of disability or death, all unvested stock options granted within 12 months prior to termination fully vest. Termination for any other reason results in forfeiture of unvested options and vested options in certain circumstances. The amortized cost of options is accelerated if the retirement eligibility date occurs before the normal vesting date. Option exercises are satisfied through the issuance of treasury shares on a first-in, first-out basis. We recognized compensation expense related to stock options of $1,697 and $4,982 for the three month and nine months ended July 31, 2023, respectively, compared to $1,580 and $5,743 for the three and nine months ended July 31, 2022, respectively.

The following table summarizes activity related to stock options for the nine months ended July 31, 2023:

	Number of Options	Weighted- Average Exercise Price  Per Share		Aggregate Intrinsic Value		Weighted Average Remaining Term
Outstanding at October 31, 2022	1,187	$	141.82
Granted	80	239.44
Exercised	(163)	115.67
Forfeited or expired	(10)	206.93
Outstanding at July 31, 2023	1,094	$	151.09	$	111,165	5.1 years
Expected to vest	245	$	214.42	$	10,006	7.5 years
Exercisable at July 31, 2023	846	$	132.58	$	101,014	4.4 years

As of July 31, 2023, there was $7,013 of total unrecognized compensation cost related to unvested stock options. That cost is expected to be amortized over a weighted average period of approximately 1.7 years.

Page 15

Nordson Corporation

The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Nine Months Ended	July 31, 2023			July 31, 2022
Expected volatility	30.4%	-	31.8%	30.6%	-	30.8%
Expected dividend yield	1.12%	-	1.27%	0.76%	-	0.76%
Risk-free interest rate	3.79%	-	4.21%	1.36%	-	1.47%
Expected life of the option (in years)	5.0	-	6.2	5.3	-	6.2

The weighted-average expected volatility used to value the 2023 and 2022 options was 30.6% and 30.6%, respectively.

Historical information was the primary basis for the selection of the expected volatility, expected dividend yield and the expected lives of the options. The risk-free interest rate was selected based upon yields of U.S. Treasury issues with a term equal to the expected life of the option being valued.

The weighted average grant date fair value of stock options granted during the nine months ended July 31, 2023 and 2022 was $77.99 and $79.03, respectively.

The total intrinsic value of options exercised during the three months ended July 31, 2023 and 2022 was $7,741 and $1,052, respectively. The total intrinsic value of options exercised during the nine months ended July 31, 2023 and 2022 was $19,873 and $10,418, respectively.

Cash received from the exercise of stock options for the nine months ended July 31, 2023 and 2022 was $18,449 and $8,845, respectively.

Restricted Shares and Restricted Share Units

We may grant restricted shares and/or restricted share units to our employees and directors. These shares or units may not be transferred for a designated period of time (generally one to three years) defined at the date of grant. We may also grant continuation awards in the form of restricted share units with cliff vesting and a performance measure that must be achieved for the restricted share units to vest.

For employee recipients, in the event of termination of employment due to early retirement, with the consent of the Company, restricted shares and units granted within 12 months prior to termination are forfeited, and other restricted shares and units vest on a pro-rata basis, subject to the consent of the Compensation Committee. In the event of termination of employment due to normal retirement at age 65, restricted shares and units granted within 12 months prior to termination are forfeited, and, for other restricted shares and units, the restriction period applicable to restricted shares will lapse and the shares will vest and be transferable and all unvested units will become vested in full, subject to the consent of the Compensation Committee. In the event of a recipient's disability or death, all restricted shares and units granted within 12 months prior to termination fully vest. Termination for any other reason prior to the lapse of any restrictions or vesting of units results in forfeiture of the shares or units.

For non-employee directors, all restrictions lapse in the event of disability or death of the non-employee director. Termination of service as a director for any other reason within one year of date of grant results in a pro-rata vesting of shares or units.

As shares or units are issued, deferred stock-based compensation equivalent to the fair value on the date of grant is expensed over the vesting period.  

The following table summarizes activity related to restricted shares during the nine months ended July 31, 2023:

	Number of Shares	Weighted-Average Grant Date Fair Value
Restricted shares at October 31, 2022	6	$	167.99
Vested	(6)	167.99
Restricted shares at July 31, 2023	—	$	—

As of July 31, 2023, there was no unrecognized compensation cost related to restricted shares. The amount charged to expense related to restricted shares during the three months ended July 31, 2023 and 2022 was $73 and $243, respectively, which included common share dividends of $2 and $4, respectively. For the nine months ended July 31, 2023 and 2022, the amounts charged to expense related to restricted shares were $336 and $856, respectively, which included common shares dividends of $5 and $14, respectively.

Page 16

Nordson Corporation

The following table summarizes activity related to restricted share units during the nine months ended July 31, 2023:

	Number of Units	Weighted-Average Grant Date Fair Value
Restricted share units at October 31, 2022	81	$	223.77
Granted	39	237.18
Forfeited	(5)	241.37
Vested	(45)	219.06
Restricted share units at July 31, 2023	70	$	232.88

As of July 31, 2023, there was $10,080 of remaining expense to be recognized related to outstanding restricted share units, which is expected to be recognized over a weighted average period of 1.8 years. The amount charged to expense related to restricted share units during each of the three months ended July 31, 2023 and 2022 was $2,152 and $2,154, respectively, compared to $6,658 and $6,246 for the nine months ended July 31, 2023 and 2022, respectively.

Performance Share Incentive Awards

Executive officers and selected other key employees are eligible to receive common share-based incentive awards. Payouts, in the form of unrestricted common shares, vary based on the degree to which corporate financial performance exceeds predetermined threshold, target and maximum performance goals over three-year performance periods. No payout will occur unless threshold performance is achieved.

The amount of compensation expense is based upon current performance projections and the percentage of the requisite service that has been rendered. The calculations are based upon the grant date fair value, which is principally driven by the stock price on the date of grant or a Monte Carlo valuation for awards with market conditions. The per share values were $231.34, $211.25 and $214.51 in 2023, and $260.60, $273.50 and $221.94 for 2022. The amount charged to expense related to performance awards for the three months ended July 31, 2023 and 2022 was $1,831 and $3,555, respectively, compared to charges of $4,785 and $10,296 for the nine months ended July 31, 2023 and 2022, respectively. As of July 31, 2023, there was $7,947 of unrecognized compensation cost related to performance share incentive awards.

Deferred Compensation

Our executive officers and other highly compensated employees may elect to defer up to 100% of their base pay and cash incentive compensation, and for executive officers, up to 90% of their share-based performance incentive payout each year. Additional share units are credited for quarterly dividends paid on our common shares. Expense related to dividends paid under this plan for the three months ended July 31, 2023 and 2022 was $30 and $17, respectively, compared to $77 and $53 for the nine months ended July 31, 2023 and 2022, respectively.

Deferred Directors' Compensation

Non-employee directors may defer all or part of their cash and equity-based compensation until retirement. Cash compensation may be deferred as cash or as share equivalent units. Deferred cash amounts are recorded as liabilities, and share equivalent units are recorded as equity. Additional share equivalent units are earned when common share dividends are declared.

The following table summarizes activity related to director deferred compensation share equivalent units during the nine months ended July 31, 2023:

	Number of Shares	Weighted-Average Grant Date Fair Value
Outstanding at October 31, 2022	90	$	77.70
Distributions	(13)	52.50
Outstanding at July 31, 2023	78	$	84.02

The amount charged to expense related to director deferred compensation for the three months ended July 31, 2023 and 2022 was $76 and $73, respectively, compared to $234 and $224 for the nine months ended July 31, 2023 and 2022, respectively.

Page 17

Nordson Corporation

Warranties

We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions is adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheets.  

Following is a reconciliation of the product warranty liability for the nine months ended July 31, 2023 and 2022:

	July 31, 2023		July 31, 2022
Beginning balance at October 31	$	11,723	$	11,113
Accruals for warranties	14,938		12,496
Warranty payments	(12,939)		(10,704)
Currency effect	566		(676)
Ending balance	$	14,288	$	12,229

Operating segments

We conduct business in three primary operating segments: Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions. The composition of segments and measure of segment profitability is consistent with that used by our chief operating decision maker. The primary measure used by the chief operating decision maker for purposes of making decisions about allocating resources to the segments and assessing performance is operating profit, which equals sales less cost of sales and certain operating expenses. Items below the operating profit line of the Condensed Consolidated Statements of Income (interest and investment income, interest expense and other income/expense) are excluded from the measure of segment profitability reviewed by our chief operating decision maker and are not presented by operating segment. The accounting policies of the segments are the same as those described in the Significant accounting policies Note.

Industrial Precision Solutions: This segment focuses on delivering proprietary dispensing and processing technology, both standard and highly customized equipment, to diverse end markets. Product lines commonly reduce material consumption, increase line efficiency through precision dispense and measurement and control, and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This segment primarily serves the industrial, consumer durables and non-durables markets.

Medical and Fluid Solutions: This segment includes the Company’s fluid management solutions for medical, high-tech industrial and other diverse end markets. Related plastic tubing, balloons, catheters, syringes, cartridges, tips and fluid connection components are used to dispense or control fluids within customers’ medical devices or products, as well as production processes.

Advanced Technology Solutions: This segment focuses on products serving electronics end markets. Advanced Technology Solutions products integrate our proprietary product technologies found in progressive stages of an electronics customer’s production processes, such as surface treatment, precisely controlled dispensing of material and test and inspection to ensure quality and reliability. Applications include, but are not limited to, semiconductors, printed circuit boards, electronic components and automotive electronics.

Page 18

Nordson Corporation

The following table presents information about our segments:

Three Months Ended	Industrial Precision Solutions		Medical and Fluid Solutions		Advanced Technology Solutions		Corporate		Total
July 31, 2023
Net external sales	$	338,257	$	170,871	$	139,549	$	—	$	648,677
Operating profit (loss)	115,346		54,019		27,083		(25,452)		170,996
July 31, 2022
Net external sales	$	341,215	$	177,840	$	143,073	$	—	$	662,128
Operating profit (loss)	119,706		58,103		28,155		(21,046)		184,918
Nine Months Ended
July 31, 2023
Net external sales	$	985,610	$	491,683	$	432,026	$	—	$	1,909,319
Operating profit (loss)	329,439		141,326		70,136		(53,179)		487,722
July 31, 2022
Net external sales	$	981,582	$	508,836	$	416,279	$	—	$	1,906,697
Operating profit (loss)	324,089		165,510		95,533		(60,381)		524,751

We had significant sales in the following geographic regions:

	Three Months Ended				Nine Months Ended
	July 31, 2023		July 31, 2022		July 31, 2023		July 31, 2022
Americas	$	290,515	$	279,205	$	834,125	$	792,859
Europe	167,536		151,659		498,379		479,900
Asia Pacific	190,626		231,264		576,815		633,938
Total net external sales	$	648,677	$	662,128	$	1,909,319	$	1,906,697

Fair value measurements

The inputs to the valuation techniques used to measure fair value are classified into the following categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis:

July 31, 2023	Total		Level 1		Level 2		Level 3
Assets:
Foreign currency forward contracts (a)	$	9,608	$	—	$	9,608	$	—
Net investment contracts (b)	3,036		—		3,036		—
Total assets at fair value	$	12,644	$	—	$	12,644	$	—
Liabilities:
Deferred compensation plans (c)	$	10,636	$	—	$	10,636	$	—
Foreign currency forward contracts (a)	4,209		—		4,209		—
Net investment contracts (b)	4,601		—		4,601		—
Total liabilities at fair value	$	19,446	$	—	$	19,446	$	—

Page 19

Nordson Corporation

October 31, 2022	Total		Level 1		Level 2		Level 3
Assets:
Foreign currency forward contracts (a)	$	5,035	$	—	$	5,035	$	—
Total assets at fair value	$	5,035	$	—	$	5,035	$	—
Liabilities:
Deferred compensation plans (b)	$	9,076	$	—	$	9,076	$	—
Foreign currency forward contracts (a)	11,724		—		11,724		—
Total liabilities at fair value	$	20,800	$	—	$	20,800	$	—

(a)We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges.

(b)Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. The notional amount of our net investment hedge contracts as of July 31, 2023 was $385,000.

(c)Executive officers and other highly compensated employees may defer up to 100% of their salary and annual cash incentive compensation and for executive officers, up to 90% of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.

The carrying amounts and fair values of financial instruments, other than cash and cash equivalents, receivables, and accounts payable, are shown in the table below. The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments.

	July 31, 2023
	Carrying Amount		Fair Value
Long-term debt (including current portion)	$	838,098	$	836,098

Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy. The carrying amount of long-term debt is shown net of unamortized debt issuance costs as disclosed in the Long-term Debt Note.

Derivative financial instruments  

Foreign Currency Forward Contracts

We operate internationally and enter into intercompany transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. Accordingly, the changes in the fair value of the foreign currency forward contracts are recognized in each accounting period in “Other – net” on the Condensed Consolidated Statements of Income together with the transaction gain or loss from the related balance sheet position.

For the three months ended July 31, 2023, we recognized a net loss of $93 on foreign currency forward contracts and a net loss of $885 from the change in fair value of balance sheet positions. For the three months ended July 31, 2022, we recognized a net gain of $15,181 on foreign currency forward contracts and a net loss of $14,436 from the change in fair value of balance sheet positions. For the nine months ended July 31, 2023, we recognized a net gain of $12,086 on foreign currency forward contracts and a net loss of $19,710 from the change in fair value of balance sheet positions. For the nine months ended July 31, 2022, we recognized a net gain of $2,503 on foreign currency forward contracts and a net loss of $394 from the change in fair value of balance sheet positions. The fair values of our foreign currency forward contract assets and liabilities are included in Receivable-net and Accrued liabilities, respectively, in our Consolidated Balance Sheets.

Page 20

Nordson Corporation

The following table summarizes, by currency, the foreign currency forward contracts outstanding at July 31, 2023 and 2022:

July 31, 2023 contract amounts:	Notional Sell Amounts		Notional Buy Amounts
Euro	$	95,064	$	194,850
British pound	20,489		132,956
Japanese yen	23,195		17,908
Mexican Peso	3,227		28,158
Hong Kong dollar	2,080		7,265
Singapore dollar	60		19,817
Australian dollar	—		9,236
Taiwan Dollar	—		8,000
Others	2,602		71,830
Total	$	146,717	$	490,020
July 31, 2022 contract amounts:	Notional Sell Amounts		Notional Buy Amounts
Euro	$	88,275	$	333,285
British pound	36,779		78,942
Japanese yen	16,688		37,163
Hong Kong dollar	—		67,341
Singapore dollar	378		18,025
Australian dollar	278		9,426
Others	26,012		98,113
Total	$	168,410	$	642,295

We are exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments. These financial instruments include cash deposits and foreign currency forward contracts. We periodically monitor the credit ratings of these counterparties in order to minimize our exposure. Our customers represent a wide variety of industries and geographic regions. For the three and nine months ended July 31, 2023 and 2022, there were no significant concentrations of credit risk.

Net Investment Hedges

Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We may utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries.

During the second quarter of 2023, the Company designated €180,000 of borrowings as a hedge of our net investment in certain foreign subsidiaries to mitigate the foreign exchange risk associated with certain investments in these subsidiaries. On June 30, 2023, the hedge was terminated. Any increase or decrease related to the remeasurement of the €180,000 borrowing into U.S. dollars was recorded in the currency translation component of Accumulated other comprehensive income (loss) within Shareholders' Equity in the Consolidated Balance Sheet. A gain of $1,144, net of tax, and a loss of $2,467, net of tax, was recorded on these net investment hedges for the three and nine months ended July 31, 2023, respectively.

During the quarter ended July 31, 2023, the Company entered into various cross currency swaps between the U.S. Dollar and Euro, Japanese Yen, Taiwan Dollar and Chinese Yuan which were designated as a hedges of our net investments in certain foreign subsidiaries to mitigate the foreign exchange risk associated with certain investments in these subsidiaries. Any increases or decreases related to the remeasurement of the hedges are recorded in the currency translation component of Accumulated other comprehensive income (loss) within Shareholders' Equity in the Consolidated Balance Sheet until the sale or substantial liquidation of the underlying investments. A loss of $1,205, net of tax, was recorded for both the three and nine months ended July 31, 2023.

Page 21

Nordson Corporation

The following table summarizes the fair values of our net investment contracts designated as net investment hedges in the Company's Consolidated Balance Sheets as of July 31, 2023:

	Prepaid expenses and other current assets		Other assets		Accrued liabilities		Other long-term liabilities
Net investment contracts	$	2,977	$	59	$	841	$	3,760

Long-term debt

A summary of long-term debt is as follows:

	July 31, 2023		October 31, 2022
Revolving credit agreement, due 2028	$	200,000	$	—
Senior notes, due 2023-2025	32,000		55,500
Senior notes, due 2023-2027	54,286		71,429
Senior notes, due 2023-2030	260,000		350,000
Term loan due 2026	300,000		—
Euro Loan	—		261,893
	846,286		738,822
Less current maturities and notes payable	110,643		392,537
Less unamortized debt issuance costs	8,188		965
Long-term maturities	$	727,455	$	345,320

Revolving credit agreement, due 2028 — In June 2023, we entered into a $1,150,000 unsecured multi-currency credit facility with a group of banks, which provides for a term loan facility in the aggregate principal amount of $300,000 (the "Term Loan Facility"), maturing in June 2026, and a multicurrency revolving credit facility in the aggregate principal amount of $850,000 (the "Revolving Facility"), maturing in June 2028 (the "New Credit Agreement"). The Company borrowed and has outstanding $300,000 on the Term Loan Facility on June 6, 2023. The Revolving Facility permits borrowing in U.S. Dollars, Euros, Sterling, Swiss Francs, Singapore Dollars, Yen, and each other currency approved by a Revolving Facility lender. The New Credit Agreement provides that the applicable margin for (i) RFR, as defined in the New Credit Agreement, and Eurodollar Loans will range from 0.85% to 1.20% and (ii) Base Rate Loans will range from 0.00% to 0.20%, in each case, based on the Company’s Leverage Ratio (as defined in the Credit Agreement and calculated on a consolidated net debt basis). Borrowings under the New Credit Agreement bear interest at (i) either a base rate or a SOFR rate, with respect to borrowings in U.S. dollars, (ii) a eurocurrency rate, with respect to borrowings in Euros and Yen, or (iii) Daily Simple RFR, with respect to borrowings in Sterling, Swiss Francs or Singapore Dollars, plus, in each case, an applicable margin (and, solely in the case of Singapore Dollars, a spread adjustment). The applicable margin is based on the Company’s Leverage Ratio. The weighted-average interest rate at July 31, 2023 was 6.00%.

Revolving credit agreement, due 2024 — In April 2019, we entered into a $850,000 unsecured multi-currency credit facility with a group of banks, which amended, restated and extended our then existing syndicated revolving credit agreement. This facility had a five-year term expiring in April 2024 and included a $75,000 subfacility for swing-line loans. On April 17, 2023, we entered into an amendment to, among other things, replace LIBOR with SOFR, EURIBOR, SONIA and TIBOR for U.S. Dollar, Euro, British Pound Sterling and Japanese Yen borrowings, respectively. On June 6, 2023, this credit agreement was terminated and replaced by the New Credit Agreement.

Senior notes, due 2023-2025 — These unsecured fixed-rate notes entered into in 2012 with a group of insurance companies have a remaining weighted-average life of 1.25 years. The weighted-average interest rate at July 31, 2023 was 3.10%.

Senior notes, due 2023-2027 — These unsecured fixed-rate notes entered into in 2015 with a group of insurance companies have a remaining weighted-average life of 2.23 years. The weighted-average interest rate at July 31, 2023 was 3.11%.

Senior notes, due 2023-2030 — These unsecured fixed-rate notes entered into in 2018 with a group of insurance companies have a remaining weighted-average life of 3.13 years. The weighted-average interest rate at July 31, 2023 was 3.97%.  

Euro loan — The euro term loan facility with Bank of America Merrill Lynch International Limited was due in March 2023 and was repaid.

We were in compliance with all covenants at July 31, 2023, and the amount we could borrow would not have been limited by any debt covenants.

Page 22

Nordson Corporation

Contingencies

We are involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee and other matters arising from the normal course of business.  Including the environmental matters discussed below, after consultation with legal counsel, we do not believe that losses in excess of the amounts we have accrued would have a material adverse effect on our financial condition, quarterly or annual operating results or cash flows.

Environmental

We have voluntarily agreed with the City of New Richmond, Wisconsin and other potentially responsible parties to share costs associated with the remediation of the City of New Richmond municipal landfill (the Site) and the construction of a potable water delivery system serving the impacted area down gradient of the Site. As of July 31, 2023 and October 31, 2022, our accrual for the ongoing operation, maintenance and monitoring obligation at the Site was $266 and $266, respectively. The liability for environmental remediation represents management’s best estimate of the probable and reasonably estimable undiscounted costs related to known remediation obligations. The accuracy of our estimate of environmental liability is affected by several uncertainties such as additional requirements that may be identified in connection with remedial activities, the complexity and evolution of environmental laws and regulations, and the identification of presently unknown remediation requirements. Consequently, our liability could be greater than our current estimate. However, we do not expect that the costs associated with remediation will have a material adverse effect on our financial condition or results of operations.

Subsequent Event

On August 24, 2023, the Company completed the acquisition of the ARAG Group and its subsidiaries (ARAG Group or ARAG) pursuant to the terms of the Sale and Purchase Agreement, dated as of June 25, 2023, by and among the Company, its Italian subsidiary, Capvis Equity V LP (Capvis), DRIP Co-Investment (DRIP), and certain individuals (the Individual Sellers, and together with Capvis and DRIP, collectively, the Sellers). ARAG is a global market and innovation leader in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. ARAG will operate as a division of our Industrial Precision Solutions segment. In anticipation of the acquisition, the Company entered into a €760,000 senior unsecured term loan facility with a group of banks in August 2023 (the Term Facility). The Term Facility has a 364-day term and matures in August 2024, and loans under the facility bear interest at a eurocurrency rate plus an applicable margin that will range from 1.1250% to 1.625% based on the Company’s Leverage Ratio (as defined in the term loan credit agreement and calculated on a consolidated net debt basis). The all-cash ARAG acquisition of approximately €957,000, net of the repayment of approximately €30,300 of debt of the acquired companies, was funded using the Term Facility and Revolving Facility. The financial results of the ARAG Group acquisition are not expected to have a material impact on our Consolidated Financial Statements.

Page 23

Nordson Corporation

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following is management's discussion and analysis of certain significant factors affecting our financial condition and results of operations for the periods included in the accompanying condensed consolidated financial statements.

Overview

Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework to deliver top tier growth with leading margins and returns. The Company’s direct sales model and applications expertise serves global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has approximately 7,200 employees with operations and support offices in over 35 countries.

COVID-19 Update

In December 2019, a novel strain of coronavirus (COVID-19) emerged and spread to other countries, including the United States. In March 2020, the World Health Organization declared COVID-19 as a pandemic (the COVID-19 pandemic). The COVID-19 pandemic, including multiple variants, resulted in governments around the world implementing stringent measures to help control the spread of the virus, including quarantines, “shelter in place” and “stay at home” orders, travel restrictions, business interruptions and other measures.

Although the World Health Organization declared an end to the COVID-19 pandemic on May 5, 2023, we continue to actively monitor the impact of COVID-19, which has negatively disrupted, and may continue to negatively disrupt, our business and results of operations in the future. For example, in the first quarter of 2023, our revenue growth in Asia-Pacific was negatively impacted by labor shortages and business disruption from the spread of COVID-19. The full extent of COVID-19 on our operations and the markets we serve remains uncertain and will depend largely on future developments related to COVID-19, including infection rates increasing or returning in various geographic areas, variations of COVID-19, actions by government authorities to contain the outbreak or treat its impact, such as reimposing previously lifted measures or putting in place additional restrictions, and the widespread distribution and acceptance of an effective vaccine, among other things. Future developments regarding COVID-19 and its effects cannot be accurately predicted.

Acquisitions

On August 24, 2023, the Company completed the acquisition of the ARAG Group and its subsidiaries (ARAG Group or ARAG) pursuant to the terms of the Sale and Purchase Agreement, dated as of June 25, 2023, by and among the Company, its Italian subsidiary, Capvis Equity V LP (Capvis), DRIP Co-Investment (DRIP), and certain individuals (the Individual Sellers, and together with Capvis and DRIP, collectively, the Sellers). ARAG is a global market and innovation leader in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. ARAG will operate as a division of our Industrial Precision Solutions segment. In anticipation of the acquisition, the Company entered into a €760,000 senior unsecured term loan facility with a group of banks in August 2023 (the Term Facility). The Term Facility has a 364-day term and matures in August 2024, and loans under the facility bear interest at a eurocurrency rate plus an applicable margin that will range from 1.1250% to 1.625% based on the Company’s Leverage Ratio (as defined in the term loan credit agreement and calculated on a consolidated net debt basis). The all-cash ARAG acquisition of approximately €957,000, net of the repayment of approximately €30,300 of debt of the acquired companies, was funded using the Term Facility and Revolving Facility. The financial results of the ARAG Group acquisition are not expected to have a material impact on our Consolidated Financial Statements.

On November 3, 2022, the Company completed the acquisition of CyberOptics Corporation (CyberOptics) pursuant to the terms of the Agreement and Plan of Merger, dated as of August 7, 2022, by and among the Company, Meta Merger Company and CyberOptics. CyberOptics is a leading global developer and manufacturer of high-precision 3D optical sensing technology solutions. The CyberOptics acquisition expanded our test and inspection platform, providing differentiated technology that expands our product offering in the semiconductor and electronics industries and will be reported in our Advanced Technology Solutions segment. The all-cash transaction of approximately $378,000, net of cash acquired, was funded using borrowings under our revolving credit facility and cash on hand and is not expected to have a material impact on our Consolidated Financial Statements.

Critical Accounting Policies and Estimates

A comprehensive discussion of the Company’s critical accounting policies and management estimates and significant accounting policies followed in the preparation of the financial statements is included in Item 7 of our Annual Report on Form 10-K for the year ended October 31, 2022 (the 2022 Form 10-K). There have been no significant changes in critical accounting policies, management estimates or accounting policies followed since the year ended October 31, 2022.

Page 24

Nordson Corporation

Results of Operations

Three months ended July 31, 2023

Worldwide sales for the three months ended July 31, 2023, were $648,677, a decrease of 2.0% from sales of $662,128 for the comparable period of 2022. The decrease consisted of a 4.5% decrease in organic sales, which was partially offset by a 2.4% increase due to an acquisition and a favorable effect from currency translation of 0.1%. The organic sales decrease was driven by ongoing pressure in electronics, primarily semiconductor dispense applications, and biopharma end markets, offset by strong growth in medical interventional solutions and polymer processing product lines.

In the Americas region, sales were $290,515 for the three months ended July 31, 2023, an increase of 4.1% from the comparable period of 2022, consisting of an organic sales increase of 2.2%, an increase due to an acquisition of 1.2%, and favorable currency effects of 0.7%. In the Asia Pacific region, sales were $190,626, a decrease of 17.6% from the comparable period of 2022, consisting of an organic sales decrease of 20.0% and unfavorable currency effects of 1.9%, partially offset by a 4.3% increase due to an acquisition. In Europe, sales were $167,536, an increase of 10.5% from the comparable period of 2022, consisting of an organic sales increase of 5.7%, favorable currency effects of 3.4%, and a 1.4% increase due to an acquisition.

Cost of sales for the three months ended July 31, 2023 were $288,357, down from $296,544 in the comparable period of 2022. Gross profit, expressed as a percentage of sales, increased to 55.5% from 55.2% in the comparable period of 2022. The 0.3 improvement was primarily driven by improved manufacturing efficiency and price realization offset by severance-related cost structure simplification actions.

Selling and administrative expenses for the three months ended July 31, 2023 were $189,324, up from $180,666 in the comparable period of 2022. The 4.8% increase was primarily driven by the first-year effect of an acquisition and related acquisition costs, partially offset by lower base business and incentive costs.

Operating profit decreased to $170,996 for the three months ended July 31, 2023, compared to $184,918 in the comparable period of 2022. Operating profit as a percentage of sales decreased to 26.4% for the three months ended July 31, 2023, compared to 27.9% in the comparable period of 2022. The 1.5 percentage point decline in operating margin was primarily driven by lower sales volume and acquisition related costs.

Interest expense for the three months ended July 31, 2023 was $12,089, compared to $5,737 in the comparable period of 2022. The increase, compared to the prior year period, was primarily due to higher average debt levels, partially due to the CyberOptics acquisition, as well as increases in interest rates. Other income was $2,542 compared to $752 in the comparable period of 2022. Included in 2023 other income were pension and postretirement income of $1,343 and $886 of foreign currency losses. Included in 2022 other expense were pension and postretirement costs of $25 and $745 in foreign currency gains.

Net income for the three months ended July 31, 2023 was $127,891, or $2.22 per diluted share, compared to $141,811, or $2.45 per diluted share, in the same period of 2022. This represents a 9.8% decrease in net income, and a 9.4% decrease in diluted earnings per share. The decrease in income was driven by lower operating profit and increased interest expense.

Industrial Precision Solutions

Sales of the Industrial Precision Solutions segment were $338,257 in the three months ended July 31, 2023, a decrease of 0.9% from sales of $341,215 for the comparable period of 2022. The decrease consisted of an organic sales decrease of 1.5%, which was partially offset by favorable currency effects of 0.6%. The organic sales decrease was driven primarily by our product assembly and nonwovens product lines in Asia Pacific, partially offset by continued strength in the polymer processing product lines.

Operating profit as a percentage of sales decreased to 34.1% for the three months ended July 31, 2023, compared to 35.1% in the comparable period of 2022. The 1.0 percentage point decline in operating margin was primarily driven by lower sales volume and unfavorable sales mix.

Medical and Fluid Solutions

Sales of the Medical and Fluid Solutions segment were $170,871 in the three months ended July 31, 2023, a decrease of 3.9% from sales of $177,840 for the comparable period of 2022. The decrease consisted of an organic sales decrease of 3.9%, which was driven by continued softness in the medical fluid components and fluid solutions product lines, partially offset by strong double-digit demand for medical interventional solutions product lines.

Operating profit as a percentage of sales decreased to 31.6% for the three months ended July 31, 2023, compared to 32.7% in the comparable period of 2022. The 1.1 percentage point decline in operating margin was primarily due to lower sales volume and sales mix changes within medical product lines.

Page 25

Nordson Corporation

Advanced Technology Solutions

Sales of the Advanced Technology Solutions segment were $139,549 in the three months ended July 31, 2023, a decrease of 2.5% from sales of $143,073 for the comparable period of 2022. The decrease consisted of an organic sales decrease of 12.8% and unfavorable currency effects of 0.4%, partially offset by a 10.7% increase due to an acquisition. The organic sales decrease was driven by electronics dispense products serving semiconductor end markets, predominantly in Asia Pacific, slightly offset by continued growth in test and inspection product lines.

Operating profit as a percentage of sales decreased to 19.4% for the three months ended July 31, 2023, compared to 19.7% in the comparable period of 2022. The 0.3 percentage point decline in operating margin was driven by severance costs, partially offset by favorable sales mix and realization of cost savings actions.

Nine months ended July 31, 2023

Worldwide sales for the nine months ended July 31, 2023 were $1,909,319, an increase of 0.1% from sales of $1,906,697 for the comparable period of 2022. The increase consisted of a 2.6% increase due to an acquisition, substantially offset by unfavorable currency translation effects of 1.8% and a 0.7% decrease in organic sales volume. Strength in the polymer processing and medical interventional solutions product lines was offset by weakness in the electronic dispense, fluid solutions, and medical fluid components product lines.

In the Americas region, sales were $834,125 for the nine months ended July 31, 2023, an increase of 5.2% from the comparable period of 2022, consisting of an organic sales increase of 3.2%, an increase due to an acquisition of 1.9%, and a favorable effect from currency translation of 0.1%. In the Asia Pacific region, sales were $576,815, a decrease of 9.0% from the comparable period of 2022, consisting of an organic sales decrease of 9.7% and a 3.7% decrease from unfavorable currency translation effects, partially offset by a 4.4% increase due to an acquisition. In Europe, sales were $498,379, an increase of 3.9% from the comparable period of 2022, consisting of an organic sales increase of 4.3% and a 1.6% increase due to an acquisition, partially offset by unfavorable currency effects of 2.0%.

Cost of sales for the nine months ended July 31, 2023 were $868,007, up from $843,344 in the comparable period of 2022. Gross profit, expressed as a percentage of sales, decreased to 54.5% from 55.8% in the comparable period of 2022. The 1.3 percentage point decrease in gross margin was driven by reduced manufacturing efficiency and severance in sites dealing with meaningful volume decreases and incremental inventory step-up amortization of $2,743 incurred in the first quarter of 2023 compared to 2022.

Selling and administrative expenses for the nine months ended July 31, 2023 were $553,590, up from $538,602 in the comparable period of 2022. The 2.8% increase was primarily driven by the first-year effect of an acquisition and acquisition related costs, partially offset by favorable currency translation effects and lower incentive costs.

Operating profit decreased to $487,722 for the nine months ended July 31, 2023, compared to $524,751 in the comparable period of 2022. Operating profit as a percentage of sales decreased to 25.5% for the nine months ended July 31, 2023, compared to 27.5% in the comparable period of 2022. The 2.0 percentage point decline in operating margin was primarily driven by unfavorable sales mix, and a combination of fees, severance, and non-cash inventory charges associated with the CyberOptics and ARAG Group acquisitions.

Interest expense for the nine months ended July 31, 2023 was $32,532, compared to $16,748 in the comparable period of 2022. The increase, compared to the prior year period, was primarily due to higher average debt levels, partially due to the CyberOptics acquisition, as well as increases in interest rates. Other expense was $2,059 compared to $37,720 in the comparable period of 2022. Included in 2023 other expense were pension income of $4,044 and $7,625 in foreign currency losses. Included in 2022 other expense were non-cash pension settlement charges of $41,221 related to the purchase of an annuity contract to relieve the Company of certain pension benefit obligations, other pension and postretirement income of $1,002 and $2,109 in foreign currency gains.

Net income for the nine months ended July 31, 2023 was $359,715, or $6.24 per diluted share, compared to $371,854, or $6.37 per diluted share, in the same period of 2022. This represents a 3.3% decrease in net income, and a 2.0% decrease in diluted earnings per share. Net income for the nine months ended July 31, 2022 included after tax non-cash pension settlement charges of $32,450, or $0.56 per diluted share, related to the purchase of an annuity contract to relieve the Company of certain pension benefit obligations. Excluding the prior year pension settlement charges, the decrease was driven primarily by a combination of lower margins; fees, severance and non-cash inventory charges associated with the CyberOptics and ARAG Group acquisitions and higher interest expense.

Page 26

Nordson Corporation

Industrial Precision Solutions

Sales of the Industrial Precision Solutions segment were $985,610 in the nine months ended July 31, 2023, an increase of 0.4% from sales of $981,582 for the comparable period of 2022. The increase consisted of an organic sales increase of 2.6%, partially offset by unfavorable currency effects that decreased sales by 2.2%. The organic sales increase was driven primarily by strong demand in polymer processing product lines.

Operating profit as a percentage of sales increased to 33.4% for the nine months ended July 31, 2023, compared to 33.0% in the comparable period of 2022. The 0.4 percentage point improvement in operating margin was primarily due to non-recurring inventory step-up amortization incurred in the first quarter of 2022 compared to 2023.

Medical and Fluid Solutions

Sales of the Medical and Fluid Solutions segment were $491,683 in the nine months ended July 31, 2023, a decrease of 3.4% from sales of $508,836 for the comparable period of 2022. The decrease consisted of an organic sales decrease of 2.4% and unfavorable currency effects that decreased sales by 1.0%. The organic sales decrease was driven by lower demand for the medical fluid components and fluid solutions product lines, partially offset by strong demand for medical interventional solutions product lines.

Operating profit as a percentage of sales decreased to 28.7% for the nine months ended July 31, 2023, compared to 32.5% in the comparable period of 2022. The 3.8 percentage point decline in operating margin was primarily due to meaningful sales mix changes within medical product lines and related factory inefficiencies due to reduced volumes.

Advanced Technology Solutions

Sales of the Advanced Technology Solutions segment were $432,026 in the nine months ended July 31, 2023, an increase of 3.8% from sales of $416,279 for the comparable period of 2022. The increase was the result of a 12.2% increase due to an acquisition, partially offset by an organic sales volume decrease of 6.6% and unfavorable currency effects of 1.8%. The organic sales decrease was driven by lower demand in electronic dispense product lines, partially offset by stronger demand in test and inspection product lines.

Operating profit as a percentage of sales decreased to 16.2% for the nine months ended July 31, 2023, compared to 22.9% in the comparable period of 2022. The 6.7 percentage point decline in operating margin was primarily due to fees, severance and non-cash inventory charges of $10,295 associated with the CyberOptics acquisition incurred in the first quarter of 2023 and factory inefficiencies due to reduced volumes.

Income taxes

We record our interim provision for income taxes based on our estimated annual effective tax rate, as well as certain items discrete to the current period. Significant judgment is involved regarding the application of global income tax laws and regulations and when projecting the jurisdictional mix of income. We have considered several factors in determining the probability of realizing deferred income tax assets which include forecasted operating earnings, available tax planning strategies and the time period over which the temporary differences will reverse. We review our tax positions on a regular basis and adjust the balances as new information becomes available. The effective tax rate for the three and nine months ended July 31, 2023 was 21.1% and 20.9%, respectively, compared to 21.4% and 21.2% for the three and nine months ended July 31, 2022, respectively.

Due to our share-based payment transactions, our income tax provision included a discrete tax benefit of $996 and $2,745 for the three months and nine months ended July 31, 2023, respectively, compared to $115 and $1,539 for the three and nine months ended July 31, 2022, respectively.

Foreign Currency Effects

In the aggregate, average exchange rates for 2023 used to translate international sales and operating results into U.S. dollars were generally unfavorable compared with average exchange rates existing during 2022. It is not possible to precisely measure the impact on operating results arising from foreign currency exchange rate changes, because of changes in selling prices, sales volume, product mix and cost structure in each country in which we operate. However, if transactions for the three months ended July 31, 2023 were translated at exchange rates in effect during the same period of 2022, we estimated that sales would have been approximately $4,000 lower while costs of sales and selling and administrative expenses would have been approximately $3,000 lower. If transactions for the nine months ended July 31, 2023 were translated at exchange rates in effect during the same period of 2022, we estimated that sales would have been approximately $35,000 higher while costs of sales and selling and administrative expenses would have been approximately $23,000 higher.

Page 27

Nordson Corporation

Financial Condition

Liquidity and Capital Resources

During the nine months ended July 31, 2023, cash and cash equivalents decreased $20,319. Cash provided by operations during this period was $478,072 compared to $339,691 for the nine months ended July 31, 2022. Changes in operating assets and liabilities increased cash by $19,197 in the nine months ended July 31, 2023 and decreased cash by $162,333 in the comparable period of 2022, driven primarily by improvements in accounts receivable and inventory, as well as cash inflows related to settlement of foreign exchange contracts.

Cash used in investing activities was $401,996 for the nine months ended July 31, 2023, compared to $210,571 used in the comparable period of 2022. During the nine months ended July 31, 2023, cash of $377,843 was used for the CyberOptics acquisition and cash of $24,244 was used for capital expenditures. During the nine months ended July 31, 2022, cash of $171,613 was used for the NDC acquisition and $39,373 was used for capital expenditures.

Cash used in financing activities was $102,074 for the nine months ended July 31, 2023, compared to $294,418 in the comparable period of 2022. In the nine months ended July 31, 2023, cash of $111,547 was used for dividend payments and cash of $78,163 was used for the purchase of treasury shares, versus $88,675 and $233,767, respectively, in the comparable period of 2022. The nine months ended July 31, 2023 included net borrowings of long-term debt of $73,956, used primarily to fund the acquisition of CyberOptics, compared to net borrowings of $22,905 during the nine months ended July 31, 2022.

The following is a summary of significant changes in balance sheet captions from October 31, 2022 to July 31, 2023. Inventories-net increased by $56,343, primarily as a result of the CyberOptics acquisition. Goodwill and intangibles increased by $279,630 and $58,600, respectively, due to the CyberOptics acquisition. Accrued liabilities decreased by $37,193 due primarily to incentive compensation payments made in the nine months ended July 31, 2023, and long-term debt increased principally as result of refinancing activities completed in 2023.

We believe the combination of present and expected capital resources, cash from operations and unused financing sources, such as our credit facilities, which includes our revolving credit agreement entered in June 2023 and the 364-day term loan facility utilized to fund the ARAG Group acquisition, are more than adequate to meet cash requirements for the next twelve months and for the foreseeable future thereafter. There are no significant restrictions limiting the transfer of funds from international subsidiaries to the parent Company. We were in compliance with all debt covenants as of July 31, 2023. Refer to our Long-term debt and Subsequent Event Notes in the notes to our condensed consolidated financial statements for additional details regarding our debt outstanding and Term Facility.

Safe Harbor Statements Under the Private Securities Litigation Reform Act of 1995

This Form 10-Q, particularly “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements within the meaning of the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements relate to, among other things, income, earnings, cash flows, changes in operations, operating improvements, businesses in which we operate and the United States and global economies. Statements in this quarterly report that are not historical are hereby identified as “forward-looking statements” and may be indicated by words or phrases such as “anticipates,” “supports,” “plans,” “projects,” “expects,” “believes,” “should,” “would,” “could,” “hope,” “forecast,” “management is of the opinion,” use of the future tense and similar words or phrases. These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions including the Company’s ability to complete and successfully integrate acquisitions, including the integration of CyberOptics and ARAG; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflict between Russia and Ukraine and tensions between the United States and China, acts of terror, natural disasters and pandemics, including the recent COVID-19 pandemic.

In light of these risks and uncertainties, actual events and results may vary significantly from those included in or contemplated or implied by such statements. Readers are cautioned not to place undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Factors that could cause actual results to differ materially from the expected results are discussed in Part I, Item 1A, Risk Factors in our 2022 Form 10-K.

Page 28

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Information regarding our financial instruments that are sensitive to changes in interest rates and foreign currency exchange rates was disclosed under Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in our 2022 Form 10-K. The information disclosed has not changed materially in the interim period since then.

ITEM 4. CONTROLS AND PROCEDURES

Our management with the participation of the principal executive officer (President and Chief Executive Officer) and principal financial officer (Executive Vice President, Chief Financial Officer) has reviewed and evaluated our disclosure controls and procedures (as defined in the Securities Exchange Act Rule 13a-15(e)) as of July 31, 2023. Based on that evaluation, our management, including the principal executive and financial officers, has concluded that our disclosure controls and procedures were effective as of July 31, 2023 in ensuring that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting that occurred during the three months ended July 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Page 29

Nordson Corporation

Part II – OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

See our Contingencies Note to the condensed consolidated financial statements for a discussion of our contingencies and legal matters.

ITEM 1A.    RISK FACTORS

In addition to the other information set forth in this quarterly report, you should carefully consider the risk factors disclosed in “Item 1A. Risk Factors” of our 2022 Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table summarizes common shares repurchased by the Company during the three months ended July 31, 2023:

(In whole shares)	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)	Maximum Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)
May 1, 2023 to May 31, 2023	99,982	$	216.65	99,823	$	563,389
June 1, 2023 to June 30, 2023	7,717	$	218.53	7,455	$	561,762
July 1, 2023 to July 31, 2023	905	$	240.73	—	$	561,762
Total	108,604			107,278

(1) Includes shares tendered for taxes related to stock option exercises and vesting of restricted stock.

(2) In December 2014, the board of directors authorized a $300,000 common share repurchase program. In August 2015, the board of directors authorized the repurchase of up to an additional $200,000 of the Company’s common shares. In August 2018, the board of directors authorized the repurchase of an additional $500,000 of the Company’s common shares. In September 2022, the board of directors authorized the repurchase of up to an additional $500,000 of the Company's common shares. Approximately $561,762 of the total $1,500,000 authorized remained available for share repurchases at July 31, 2023. Uses for repurchased shares include the funding of benefit programs including stock options and restricted stock. Shares purchased are treated as treasury shares until used for such purposes. The repurchase program will be funded using cash from operations and proceeds from borrowings under our credit facilities. The repurchase program does not have an expiration date.

ITEM 5. OTHER INFORMATION

On June 30, 2023, Stephen P. Lovass, an Executive Vice President of the Company, adopted a trading arrangement for the sale of the Company’s common shares (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Lovass’s Rule 10b5-1 Trading Plan, which expires no later than March 28, 2024, provides for the sale of up to 6,898 common shares pursuant to the terms of the Rule 10b5-1 Trading Plan.

Page 30

Nordson Corporation

ITEM 6. EXHIBITS

4.1	Credit Agreement, dated as of June 6, 2023, by and among Nordson Corporation and Nordson Engineering GmbH, as Borrowers, Wells Fargo Bank, National Association, as Agent, and Wells Fargo Securities, LLC, BofA Securities, Inc., JPMorgan Chase Bank, N.A., PNC Capital Markets LLC, and U.S. Bank National Association, as Joint Lead Arrangers and Bookrunners, and various financial institutions named therein as lenders. (incorporated herein by reference to Exhibit 4.1 to Registrant’s Form 8-K dated June 6, 2023)
31.1	Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 by the Chief Executive Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 by the Chief Financial Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
101	The following financial information from Nordson Corporation’s Quarterly Report on Form 10-Q for the three and nine months ended July 31, 2023 formatted in inline Extensible Business Reporting Language (iXBRL): (i) the Condensed Consolidated Statements of Income for the three and nine months ended July 31, 2023 and 2022, (ii) the Consolidated Statements of Comprehensive Income for the three and nine months ended July 31, 2023 and 2022, (iii) the Consolidated Balance Sheets at July 31, 2023 and October 31, 2022, (iv) the Consolidated Statements of Shareholders’ Equity for the three and nine months ended July 31, 2023 and 2022, (v) the Condensed Consolidated Statements of Cash Flows for the nine months ended July 31, 2023 and 2022, and (vi) the Notes to Condensed Consolidated Financial Statements.
104	The cover page from Nordson Corporation’s Quarterly Report on Form 10-Q for the quarter ended July 31, 2023, formatted in inline Extensible Business Reporting Language (iXBRL) (included in Exhibit 101).

Page 31

Nordson Corporation

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:  August 24, 2023	Nordson Corporation
	By: /s/ Joseph P. Kelley
	Joseph P. Kelley
	Executive Vice President, Chief Financial Officer
	(Principal Financial Officer)

Page 32

EX-31.1

Exhibit 31.1

CERTIFICATIONS

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Sundaram Nagarajan, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Nordson Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 24, 2023

/s/ Sundaram Nagarajan

Sundaram Nagarajan

President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Joseph P. Kelley, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Nordson Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 24, 2023

/s/ Joseph P. Kelley

Joseph P. Kelley

Executive Vice President, Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350, Chapter 63 of Title 18, United States Code), I, Sundaram Nagarajan, President and Chief Executive Officer of Nordson Corporation, an Ohio corporation (the “Company”), do hereby certify that, to the bet of my knowledge:

1.The Quarterly Report on Form 10-Q for the quarter ended July 31, 2023 of the Company (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.Information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 24, 2023	/s/ Sundaram Nagarajan
	Sundaram Nagarajan
	President and Chief Executive Officer

EX-32.2

Exhibit 32.2

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350, Chapter 63 of Title 18, United States Code), I, Joseph P. Kelley, Executive Vice President, Chief Financial Officer of Nordson Corporation, an Ohio corporation (the “Company”), do hereby certify that, to the best of my knowledge:

1.The Quarterly Report on Form 10-Q for the quarter ended July 31, 2023 of the Company (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.Information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 24, 2023	/s/ Joseph P. Kelley
	Joseph P. Kelley
	Executive Vice President, Chief Financial Officer

XML

Cover Page - shares	9 Months Ended
	Jul. 31, 2023	Aug. 22, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2023
Document Transition Report	false
Entity File Number	0-7977
Entity Registrant Name	NORDSON CORPORATION
Entity Incorporation, State or Country Code	OH
Entity Tax Identification Number	34-0590250
Entity Address, Address Line One	28601 Clemens Road
Entity Address, City or Town	Westlake
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44145
City Area Code	440
Local Phone Number	892-1580
Title of 12(b) Security	Common Shares, without par value
Trading Symbol	NDSN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		57,014,497
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000072331
Current Fiscal Year End Date	--10-31

XML

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Statement [Abstract]
Sales	$ 648,677	$ 662,128	$ 1,909,319	$ 1,906,697
Operating costs and expenses:
Cost of sales	288,357	296,544	868,007	843,344
Selling and administrative expenses	189,324	180,666	553,590	538,602
Total operating costs and expenses	477,681	477,210	1,421,597	1,381,946
Operating profit	170,996	184,918	487,722	524,751
Other income (expense):
Interest expense	(12,089)	(5,737)	(32,532)	(16,748)
Interest and investment income	603	572	1,628	1,456
Other income (expense)- net	2,542	752	(2,059)	(37,720)
Total other income (expense)	(8,944)	(4,413)	(32,963)	(53,012)
Income before income taxes	162,052	180,505	454,759	471,739
Income taxes	34,161	38,694	95,044	99,885
Net income	$ 127,891	$ 141,811	$ 359,715	$ 371,854
Average common shares (in shares)	56,989	57,409	57,114	57,782
Incremental common shares attributable to equity compensation (in shares)	541	560	543	610
Average common shares attributable and common share equivalents (in shares)	57,530	57,969	57,657	58,392
Basic earnings per share (in dollars per share)	$ 2.24	$ 2.47	$ 6.30	$ 6.44
Diluted earnings per share (in dollars per share)	$ 2.22	$ 2.45	$ 6.24	$ 6.37

XML

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 127,891	$ 141,811	$ 359,715	$ 371,854
Components of other comprehensive income (loss):
Foreign currency translation adjustments	3,455	(21,220)	79,986	(81,479)
Pension and other postretirement plan adjustments, net of tax	(159)	1,848	(908)	7,686
Total other comprehensive income (loss)	3,296	(19,372)	79,078	(41,746)
Total comprehensive income	$ 131,187	$ 122,439	$ 438,793	$ 330,108

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2023	Oct. 31, 2022
Current assets:
Cash and cash equivalents	$ 143,138	$ 163,457
Receivables - net	533,793	537,313
Inventories - net	439,741	383,398
Prepaid expenses and other current assets	60,249	48,803
Total current assets	1,176,921	1,132,971
Goodwill	2,110,780	1,804,693
Intangible assets - net	350,524	329,402
Property, plant and equipment - net	350,735	353,442
Operating right of use lease assets	104,592	102,279
Deferred income taxes	12,199	10,447
Other assets	91,281	87,141
Total assets	4,197,032	3,820,375
Current liabilities:
Current maturities of long-term debt and notes payable	110,643	392,537
Accrued liabilities	169,635	206,828
Accounts payable	105,075	99,276
Customer advanced payments	95,274	92,584
Income taxes payable	26,661	22,333
Operating lease liability - current	16,809	15,738
Finance lease liability - current	4,512	4,907
Total current liabilities	528,609	834,203
Long-term debt	727,455	345,320
Operating lease liability - noncurrent	91,287	90,768
Deferred income taxes	119,734	110,781
Postretirement obligations	57,528	56,804
Pension obligations	46,782	40,551
Finance lease liability - noncurrent	10,507	11,184
Other long-term liabilities	35,324	36,389
Shareholders' equity:
Common shares	12,253	12,253
Capital in excess of stated value	660,218	626,697
Retained earnings	3,900,384	3,652,216
Accumulated other comprehensive loss	(128,704)	(207,782)
Common shares in treasury, at cost	(1,864,345)	(1,789,009)
Total shareholders' equity	2,579,806	2,294,375
Total liabilities and shareholders' equity	$ 4,197,032	$ 3,820,375

XML

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Common Shares in Treasury, at cost
Beginning balance at Oct. 31, 2021	$ 2,159,130	$ 12,253	$ 585,334	$ 3,265,027	$ (175,835)	$ (1,527,649)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	5,721		5,046			675
Stock-based compensation	8,392		8,392
Purchase of treasury shares	(35,002)					(35,002)
Dividends declared	(29,724)			(29,724)
Net income	120,409			120,409
Components of other comprehensive income (loss):
Foreign currency translation adjustments	(13,358)				(13,358)
Defined benefit pension and post-retirement plan adjustments	3,060				3,060
Ending balance at Jan. 31, 2022	2,218,628	12,253	598,772	3,355,712	(186,133)	(1,561,976)
Beginning balance at Oct. 31, 2021	2,159,130	12,253	585,334	3,265,027	(175,835)	(1,527,649)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	371,854
Components of other comprehensive income (loss):
Foreign currency translation adjustments	(81,479)
Pension settlement, net of tax of ($0)	32,047
Ending balance at Jul. 31, 2022	2,199,045	12,253	616,567	3,548,206	(217,581)	(1,760,400)
Beginning balance at Jan. 31, 2022	2,218,628	12,253	598,772	3,355,712	(186,133)	(1,561,976)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	2,077		1,843			234
Stock-based compensation	7,394		7,394
Purchase of treasury shares	(105,464)					(105,464)
Dividends declared	(29,577)			(29,577)
Net income	109,634			109,634
Components of other comprehensive income (loss):
Foreign currency translation adjustments	(46,901)				(46,901)
Pension settlement, net of tax of ($0)	32,047				32,047
Defined benefit pension and post-retirement plan adjustments	2,778				2,778
Ending balance at Apr. 30, 2022	2,190,616	12,253	608,009	3,435,769	(198,209)	(1,667,206)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	1,047		940			107
Stock-based compensation	7,618		7,618
Purchase of treasury shares	(93,301)					(93,301)
Dividends declared	(29,374)			(29,374)
Net income	141,811			141,811
Components of other comprehensive income (loss):
Foreign currency translation adjustments	(21,220)				(21,220)
Pension settlement, net of tax of ($0)	0
Defined benefit pension and post-retirement plan adjustments	1,848				1,848
Ending balance at Jul. 31, 2022	2,199,045	12,253	616,567	3,548,206	(217,581)	(1,760,400)
Beginning balance at Oct. 31, 2022	2,294,375	12,253	626,697	3,652,216	(207,782)	(1,789,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	8,807		7,032			1,775
Stock-based compensation	7,071		7,071
Purchase of treasury shares	(6,875)					(6,875)
Dividends declared	(37,199)			(37,199)
Net income	104,261			104,261
Components of other comprehensive income (loss):
Foreign currency translation adjustments	76,821				76,821
Defined benefit pension and post-retirement plan adjustments	(576)				(576)
Ending balance at Jan. 31, 2023	2,446,685	12,253	640,800	3,719,278	(131,537)	(1,794,109)
Beginning balance at Oct. 31, 2022	2,294,375	12,253	626,697	3,652,216	(207,782)	(1,789,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	359,715
Components of other comprehensive income (loss):
Foreign currency translation adjustments	79,986
Pension settlement, net of tax of ($0)	0
Ending balance at Jul. 31, 2023	2,579,806	12,253	660,218	3,900,384	(128,704)	(1,864,345)
Beginning balance at Jan. 31, 2023	2,446,685	12,253	640,800	3,719,278	(131,537)	(1,794,109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	3,001		2,632			369
Stock-based compensation	4,970		4,970
Purchase of treasury shares	(47,490)					(47,490)
Dividends declared	(37,264)			(37,264)
Net income	127,563			127,563
Components of other comprehensive income (loss):
Foreign currency translation adjustments	(290)				(290)
Defined benefit pension and post-retirement plan adjustments	(173)				(173)
Ending balance at Apr. 30, 2023	2,497,002	12,253	648,402	3,809,577	(132,000)	(1,841,230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	6,641		5,958			683
Stock-based compensation	5,858		5,858
Purchase of treasury shares	(23,798)					(23,798)
Dividends declared	(37,084)			(37,084)
Net income	127,891			127,891
Components of other comprehensive income (loss):
Foreign currency translation adjustments	3,455				3,455
Pension settlement, net of tax of ($0)	0
Defined benefit pension and post-retirement plan adjustments	(159)				(159)
Ending balance at Jul. 31, 2023	$ 2,579,806	$ 12,253	$ 660,218	$ 3,900,384	$ (128,704)	$ (1,864,345)

XML

Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Jul. 31, 2023	Apr. 30, 2023	Jan. 31, 2023	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared (in dollars per share)	$ 0.65	$ 0.65	$ 0.65	$ 0.51	$ 0.51	$ 0.51

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Cash flows from operating activities:
Net income	$ 359,715	$ 371,854
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	80,637	75,242
Non-cash stock compensation	17,067	23,404
Deferred income taxes	(930)	(11,094)
Other non-cash expense	762	43,325
Loss on sale of property, plant and equipment	1,624	(707)
Changes in operating assets and liabilities	19,197	(162,333)
Net cash provided by operating activities	478,072	339,691
Cash flows from investing activities:
Additions to property, plant and equipment	(24,244)	(39,373)
Proceeds from sale of property, plant and equipment	91	415
Acquisition of business, net of cash acquired	(377,843)	(171,613)
Net cash used in investing activities	(401,996)	(210,571)
Cash flows from financing activities:
Proceeds from long-term debt	1,279,151	63,067
Repayment of long-term debt	(1,205,195)	(40,162)
Repayment of finance lease obligations	(4,769)	(3,726)
Issuance of common shares	18,449	8,845
Purchase of treasury shares	(78,163)	(233,767)
Dividends paid	(111,547)	(88,675)
Net cash used in financing activities	(102,074)	(294,418)
Effect of exchange rate changes on cash	5,679	(5,937)
Decrease in cash and cash equivalents	(20,319)	(171,235)
Cash and cash equivalents at beginning of period	163,457	299,972
Cash and cash equivalents at end of period	$ 143,138	$ 128,737

XML

Significant accounting policies

9 Months Ended

Jul. 31, 2023

Accounting Policies [Abstract]

Significant accounting policies

Significant accounting policies

Basis of presentation.  The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles in the United States (U.S. GAAP) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine months ended July 31, 2023 are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the Consolidated Financial Statements and notes included in our Annual Report on Form 10-K for the year ended October 31, 2022.

Consolidation.  The Condensed Consolidated Financial Statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50% or less or in which we do not have control but have the ability to exercise significant influence, are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.  

Use of estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements.  Actual amounts could differ from these estimates.

Revenue recognition. A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. Revenue for undelivered items is deferred and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of July 31, 2023 and 2022 were not material.

However, for certain contracts related to the sale of customer-specific products within our Medical and Fluid Solutions segment, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled and we are contractually entitled to payment for work performed to date plus a reasonable margin.  

As control transfers over time, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material on July 31, 2023 and October 31, 2022. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues at July 31, 2023 and October 31, 2022.

Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services.  Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred as the amortization period resulting from capitalizing the

costs is one year or less. These costs are recorded within Selling and administrative expenses in our Condensed Consolidated Statements of Income.

We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and are not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and, therefore, these items are typically regarded as inconsequential or not material.

We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to our Operating segments Note for details.

Earnings per share.  Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted shares and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options excluded from the calculation of diluted earnings per share for the three months ended July 31, 2023 and 2022 were 138 and 76, respectively. Options excluded from the calculation of diluted earnings per share for the nine months ended July 31, 2023 and 2022 were 141 and 79, respectively.

XML

Recently issued accounting standards	9 Months Ended
	Jul. 31, 2023
Accounting Changes and Error Corrections [Abstract]
Recently issued accounting standards	Recently issued accounting standardsThere have been no new accounting standards issued which would require either disclosure or adoption during the current periods.

XML

Acquisitions

9 Months Ended

Jul. 31, 2023

Business Combination and Asset Acquisition [Abstract]

Acquisitions

Acquisitions

Business acquisitions have been accounted for using the acquisition method, with the acquired assets and liabilities recorded at estimated fair value on the dates of acquisition. The cost in excess of the net assets of the business acquired is included in goodwill. Operating results since the respective dates of acquisitions are included in the Condensed Consolidated Statements of Income.

2023 Acquisitions

On August 24, 2023, the Company completed the acquisition of the ARAG Group and its subsidiaries (ARAG Group or ARAG) pursuant to the terms of the Sale and Purchase Agreement, dated as of June 25, 2023, by and among the Company, its Italian subsidiary, Capvis Equity V LP (Capvis), DRIP Co-Investment (DRIP), and certain individuals (the Individual Sellers, and together with Capvis and DRIP, collectively, the Sellers). ARAG is a global market and innovation leader in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. ARAG will operate as a division of our Industrial Precision Solutions segment. In anticipation of the acquisition, the Company entered into a €760,000 senior unsecured term loan facility with a group of banks in August 2023 (the Term Facility). The Term Facility has a 364-day term and matures in August 2024, and loans under the facility bear interest at a eurocurrency rate plus an applicable margin that will range from 1.1250% to 1.625% based on the Company’s Leverage Ratio (as defined in the term loan credit agreement and calculated on a consolidated net debt basis). The all-cash ARAG acquisition of approximately €957,000, net of the repayment of approximately €30,300 of debt of the acquired companies, was funded using the Term Facility and Revolving Facility. The financial results of the ARAG Group acquisition are not expected to have a material impact on our Consolidated Financial Statements.

On November 3, 2022, we acquired 100% of CyberOptics Corporation (CyberOptics). CyberOptics is a leading global developer and manufacturer of high-precision 3D optical sensing technology solutions. The CyberOptics acquisition expanded our test and inspection platform, providing differentiated technology that expands our product offering in the semiconductor and electronics industries and is reported in our Advanced Technology Solutions segment. We acquired CyberOptics for an aggregate purchase price of $377,843, net of cash of approximately $40,890, funded using borrowings under our revolving credit facility and cash on hand. Based on the fair value of the assets acquired and the liabilities assumed, goodwill of $279,630 and identifiable intangible assets of $58,600 were recorded. The identifiable intangible assets consist primarily of $15,200 of tradenames (amortized over fifteen years), $14,600 of technology (amortized over seven years), and $28,800 of customer contracts (amortized over twelve years). The results of CyberOptics are not material to our Consolidated Financial Statements. As of July 31, 2023, the purchase price allocation remains preliminary as we complete our assessment of intangibles and income taxes.

The assets and liabilities acquired were as follows:

	November 3, 2022
Cash	$	40,890
Receivables - net	21,364
Inventories - net	35,300
Goodwill	279,630
Intangibles	58,600
Other assets	14,046
Total Assets	$	449,830
Accounts payable	$	8,109
Deferred income taxes	14,294
Other liabilities	8,694
Total Liabilities	$	31,097

2022 Acquisition

On November 1, 2021, we acquired 100% of NDC Technologies (NDC), a leading global provider of precision measurement solutions for in-line manufacturing process control. NDC's technology portfolio includes in-line measurement sensors, gauges and analyzers using near-infrared, laser, X-ray, optical and nucleonic technologies, as well as proprietary algorithms and software. We acquired NDC for an aggregate purchase price of $171,613, net of cash of approximately $7,533 and other working capital adjustments of $2,763, utilizing cash on hand. Based on the fair value of the assets acquired and the liabilities assumed, goodwill of $131,129 and identifiable intangible assets of $31,130 were recorded. The identifiable intangible assets consist primarily of $10,800 of tradenames (amortized over thirteen years), $10,000 of technology (amortized over seven years), $9,500 of customer relationships (amortized over four years) and $830 of non-compete agreements (amortized over three years). Goodwill associated with this acquisition of $72,018 is tax deductible. This acquisition is being reported in our Industrial Precision Solutions segment and the results of NDC are not material to our Consolidated Financial Statements.

XML

Receivables

9 Months Ended

Jul. 31, 2023

Credit Loss [Abstract]

Receivables

Receivables

Our allowance for credit losses is principally determined based on aging of receivables. Receivables are exposed to credit risk based on the customers' ability to pay which is influenced by, among other factors, their financial liquidity. We perform ongoing customer credit evaluation to maintain sufficient allowances for potential credit losses. Our segments perform credit evaluation and monitoring to estimate and manage credit risk through the review of customer information, credit ratings, approval and monitoring of customer credit limits, and assessment of market conditions. We may also require prepayments or bank guarantees from customers to mitigate credit risk. Our receivables are generally short-term in nature with a majority of receivables outstanding less than 90 days. Accounts receivable balances are written-off against the allowance if deemed uncollectible.

Accounts receivable are net of an allowance for credit losses of $8,076 and $8,218 on July 31, 2023 and October 31, 2022, respectively. Provision losses related to allowance for credit losses of $410 and provision income of $239 was recorded for the three and nine months ended July 31, 2023, respectively, compared to provision expense of $788 and $1,439 for the same periods a year ago, respectively. The remaining change in the allowance for credit losses is principally related to net write-off/recoveries of uncollectible accounts as well as currency translation.

XML

Inventories

9 Months Ended

Jul. 31, 2023

Inventory Disclosure [Abstract]

Inventories

Inventories

Components of inventories were as follows:

	July 31, 2023		October 31, 2022
Finished goods	$	234,690	$	218,491
Raw materials and component parts	200,475		157,447
Work-in-process	62,856		53,195
	498,021		429,133
Obsolescence and other reserves	(58,280)		(45,735)
	$	439,741	$	383,398

See Acquisitions Note for inventory increase attributable to acquisition of CyberOptics.

XML

Property, Plant and Equipment

9 Months Ended

Jul. 31, 2023

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

Property, Plant and Equipment

Components of property, plant and equipment were as follows:

	July 31, 2023		October 31, 2022
Land	$	9,856	$	9,278
Land improvements	5,033		4,979
Buildings	282,260		271,450
Machinery and equipment	536,215		505,343
Enterprise management system	52,938		52,513
Construction-in-progress	20,130		31,466
Leased property under finance leases	28,047		27,512
	934,479		902,541
Accumulated depreciation and amortization	(583,744)		(549,099)
	$	350,735	$	353,442

Depreciation expense was $13,180 and $12,178 for the three months ended July 31, 2023 and 2022, respectively. Depreciation expense was $38,798 and $36,876 for the nine months ended July 31, 2023 and 2022, respectively.

XML

Goodwill and other intangible assets

9 Months Ended

Jul. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and other intangible assets

Goodwill and other intangible assets  

Changes in the carrying amount of goodwill for the nine months ended July 31, 2023 by operating segment were as follows:

	Industrial Precision Solutions		Medical Fluid Systems		Advanced Technology Solutions		Total
Balance at October 31, 2022	$	520,236	$	1,172,069	$	112,388	$	1,804,693
Acquisitions	—		—		279,630		279,630
Currency effect	4,744		3,869		17,844		26,457
Balance at July 31, 2023	$	524,980	$	1,175,938	$	409,862	$	2,110,780

The increase in goodwill for the nine months ended July 31, 2023 was due to the acquisition of CyberOptics. See Acquisitions Note for additional details.

Information regarding our intangible assets subject to amortization was as follows:

	July 31, 2023
	Carrying  Amount		Accumulated Amortization		Net Book  Value
Customer relationships	$	517,147	$	282,598	$	234,549
Patent/technology costs	176,396		109,783		66,613
Trade name	99,413		50,673		48,740
Non-compete agreements	10,559		9,937		622
Other	143		143		—
Total	$	803,658	$	453,134	$	350,524
	October 31, 2022
	Carrying  Amount		Accumulated Amortization		Net Book  Value
Customer relationships	$	480,058	$	250,798	$	229,260
Patent/technology costs	157,549		96,426		61,123
Trade name	82,759		44,707		38,052
Non-compete agreements	10,253		9,290		963
Other	446		442		4
Total	$	731,065	$	401,663	$	329,402

Amortization expense for the three months ended July 31, 2023 and 2022 was $13,922 and $12,709, respectively. Amortization expense for the nine months ended July 31, 2023 and 2022 was $41,839 and $38,366, respectively. See Acquisitions Note for details regarding intangibles recorded due to the acquisition of CyberOptics.

XML

Pension and other postretirement plans

9 Months Ended

Jul. 31, 2023

Retirement Benefits [Abstract]

Pension and other postretirement plans

Pension and other postretirement plans

During the second quarter of 2022, we completed a partial plan settlement transaction in regards to two of our U.S. pension plans in which plan assets amounting to $171,181 were used to purchase a group annuity contract from The Prudential Insurance Company of America (Prudential). The settlement resulted in a loss of $41,221, which is included in Other-net on the Condensed Consolidated Statements of Income. This transaction relieved the Company of its responsibility for the pension obligation related to certain retired employees and transferred the obligation and payment responsibility to Prudential for retirement benefits owed to approximately 1,500 retirees and other beneficiaries. The annuity contract covered retirees who commenced receiving benefits on or before November 1, 2021. The monthly retirement benefit payment amounts currently received by retirees and their beneficiaries did not change as a result of this transaction. Plan participants not included in the transaction remain in the plans and responsibility for payment of the retirement benefits remains with the Company.

The components of net periodic pension and other postretirement cost for the three and nine months ended July 31, 2023 and 2022 were:

	U.S.				International
Three Months Ended	2023		2022		2023		2022
Service cost	$	2,744	$	3,423	$	281	$	423
Interest cost	4,176		3,322		642		272
Expected return on plan assets	(6,529)		(5,692)		(392)		(347)
Amortization of prior service cost (credit)	—		12		(13)		(13)
Amortization of net actuarial loss	—		1,197		20		558
Total benefit cost	$	391	$	2,262	$	538	$	893
	U.S.				International
Nine Months Ended	2023		2022		2023		2022
Service cost	$	8,233	$	13,338	$	838	$	1,343
Interest cost	12,526		11,146		1,887		861
Expected return on plan assets	(19,587)		(22,082)		(1,151)		(1,109)
Amortization of prior service cost (credit)	—		36		(38)		(43)
Amortization of net actuarial loss	—		6,282		61		1,758
Settlement loss	—		41,221		—		—
Total benefit cost	$	1,172	$	49,941	$	1,597	$	2,810

The components of other postretirement benefit costs for the three and nine months ended July 31, 2023 and 2022 were:

	U.S.				International
Three Months Ended	2023		2022		2023		2022
Service cost	$	100	$	172	$	1	$	3
Interest cost	766		481		3		3
Amortization of net actuarial (gain) loss	—		244		(16)		(12)
Total benefit cost (income)	$	866	$	897	$	(12)	$	(6)
	U.S.				International
Nine Months Ended	2023		2022		2023		2022
Service cost	$	299	$	515	$	4	$	9
Interest cost	2,297		1,443		8		10
Amortization of net actuarial (gain) loss	—		733		(47)		(37)
Total benefit cost (income)	$	2,596	$	2,691	$	(35)	$	(18)

The components of net periodic pension and other postretirement cost other than service cost are included in Other – net in our Condensed Consolidated Statements of Income.

XML

Income taxes

9 Months Ended

Jul. 31, 2023

Income Tax Disclosure [Abstract]

Income taxes

Income taxes

We record our interim provision for income taxes based on our estimated annual effective tax rate, as well as certain items discrete to the current periods. The effective tax rate for the three months ended July 31, 2023 and 2022 was 21.1% and 21.4%, respectively. The effective tax rate for the nine months ended July 31, 2023 and 2022 was 20.9% and 21.2%, respectively.

Due to our share-based payment transactions, our income tax provision included a discrete tax benefit of $996 and $2,745 for the three months and nine months ended July 31, 2023, respectively, compared to $115 and $1,539 for the three and nine months ended July 31, 2022, respectively.

XML

Accumulated other comprehensive loss

9 Months Ended

Jul. 31, 2023

Equity [Abstract]

Accumulated other comprehensive loss

Accumulated other comprehensive income (loss)

The components of accumulated other comprehensive income (loss), including adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below.

	Cumulative translation adjustments		Pension and postretirement  benefit plan adjustments		Accumulated other  comprehensive income (loss)
Balance at October 31, 2022	$	(160,046)	$	(47,736)	$	(207,782)
Pension and other postretirement plan adjustments, net of tax of ($305)	—		(908)		(908)
Foreign currency translation adjustments (a)	79,986		—		79,986
Balance at July 31, 2023	$	(80,060)	$	(48,644)	$	(128,704)

(a) Includes a net loss of $3,672, net of tax of $1,097, on net investment hedges.

XML

Stock-based compensation

9 Months Ended

Jul. 31, 2023

Share-Based Payment Arrangement [Abstract]

Stock-based compensation

Stock-based compensation

During the 2021 Annual Meeting of Shareholders, our shareholders approved the Nordson Corporation 2021 Stock Incentive and Award Plan (the 2021 Plan) as the successor to the Amended and Restated 2012 Stock Incentive and Award Plan (the 2012 Plan). The 2021 Plan provides for the granting of stock options, stock appreciation rights, restricted shares, restricted share units, performance shares, cash awards and other stock or performance-based incentives. A maximum of 900 common shares were authorized for grant under the 2021 Plan plus the number of shares that remained available to be granted under the 2012 Plan, as well as issuable under the CyberOptics equity plan. As of July 31, 2023, a total of 2,012 common shares were available to be granted under the 2021 Plan.

Stock Options

Nonqualified or incentive stock options may be granted to our employees and directors. Generally, options granted to employees may be exercised beginning one year from the date of grant at a rate not exceeding 25% per year and expire 10 years from the date of grant. Vesting accelerates upon a qualified termination in connection with a change in control. In the event of termination of employment due to early retirement or normal retirement at age 65, options granted within 12 months prior to termination are forfeited, and vesting continues post retirement for all other unvested options granted. In the event of disability or death, all unvested stock options granted within 12 months prior to termination fully vest. Termination for any other reason results in forfeiture of unvested options and vested options in certain circumstances. The amortized cost of options is accelerated if the retirement eligibility date occurs before the normal vesting date. Option exercises are satisfied through the issuance of treasury shares on a first-in, first-out basis. We recognized compensation expense related to stock options of $1,697 and $4,982 for the three month and nine months ended July 31, 2023, respectively, compared to $1,580 and $5,743 for the three and nine months ended July 31, 2022, respectively.

The following table summarizes activity related to stock options for the nine months ended July 31, 2023:

	Number of Options	Weighted- Average Exercise Price  Per Share		Aggregate Intrinsic Value		Weighted Average Remaining Term
Outstanding at October 31, 2022	1,187	$	141.82
Granted	80	239.44
Exercised	(163)	115.67
Forfeited or expired	(10)	206.93
Outstanding at July 31, 2023	1,094	$	151.09	$	111,165	5.1 years
Expected to vest	245	$	214.42	$	10,006	7.5 years
Exercisable at July 31, 2023	846	$	132.58	$	101,014	4.4 years

As of July 31, 2023, there was $7,013 of total unrecognized compensation cost related to unvested stock options. That cost is expected to be amortized over a weighted average period of approximately 1.7 years.

The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Nine Months Ended	July 31, 2023			July 31, 2022
Expected volatility	30.4%	-	31.8%	30.6%	-	30.8%
Expected dividend yield	1.12%	-	1.27%	0.76%	-	0.76%
Risk-free interest rate	3.79%	-	4.21%	1.36%	-	1.47%
Expected life of the option (in years)	5.0	-	6.2	5.3	-	6.2

The weighted-average expected volatility used to value the 2023 and 2022 options was 30.6% and 30.6%, respectively.

Historical information was the primary basis for the selection of the expected volatility, expected dividend yield and the expected lives of the options. The risk-free interest rate was selected based upon yields of U.S. Treasury issues with a term equal to the expected life of the option being valued.

The weighted average grant date fair value of stock options granted during the nine months ended July 31, 2023 and 2022 was $77.99 and $79.03, respectively.

The total intrinsic value of options exercised during the three months ended July 31, 2023 and 2022 was $7,741 and $1,052, respectively. The total intrinsic value of options exercised during the nine months ended July 31, 2023 and 2022 was $19,873 and $10,418, respectively.

Cash received from the exercise of stock options for the nine months ended July 31, 2023 and 2022 was $18,449 and $8,845, respectively.

Restricted Shares and Restricted Share Units

We may grant restricted shares and/or restricted share units to our employees and directors. These shares or units may not be transferred for a designated period of time (generally one to three years) defined at the date of grant. We may also grant continuation awards in the form of restricted share units with cliff vesting and a performance measure that must be achieved for the restricted share units to vest.

For employee recipients, in the event of termination of employment due to early retirement, with the consent of the Company, restricted shares and units granted within 12 months prior to termination are forfeited, and other restricted shares and units vest on a pro-rata basis, subject to the consent of the Compensation Committee. In the event of termination of employment due to normal retirement at age 65, restricted shares and units granted within 12 months prior to termination are forfeited, and, for other restricted shares and units, the restriction period applicable to restricted shares will lapse and the shares will vest and be transferable and all unvested units will become vested in full, subject to the consent of the Compensation Committee. In the event of a recipient's disability or death, all restricted shares and units granted within 12 months prior to termination fully vest. Termination for any other reason prior to the lapse of any restrictions or vesting of units results in forfeiture of the shares or units.

For non-employee directors, all restrictions lapse in the event of disability or death of the non-employee director. Termination of service as a director for any other reason within one year of date of grant results in a pro-rata vesting of shares or units.

As shares or units are issued, deferred stock-based compensation equivalent to the fair value on the date of grant is expensed over the vesting period.  

The following table summarizes activity related to restricted shares during the nine months ended July 31, 2023:

	Number of Shares	Weighted-Average Grant Date Fair Value
Restricted shares at October 31, 2022	6	$	167.99
Vested	(6)	167.99
Restricted shares at July 31, 2023	—	$	—

As of July 31, 2023, there was no unrecognized compensation cost related to restricted shares. The amount charged to expense related to restricted shares during the three months ended July 31, 2023 and 2022 was $73 and $243, respectively, which included common share dividends of $2 and $4, respectively. For the nine months ended July 31, 2023 and 2022, the amounts charged to expense related to restricted shares were $336 and $856, respectively, which included common shares dividends of $5 and $14, respectively.

The following table summarizes activity related to restricted share units during the nine months ended July 31, 2023:

	Number of Units	Weighted-Average Grant Date Fair Value
Restricted share units at October 31, 2022	81	$	223.77
Granted	39	237.18
Forfeited	(5)	241.37
Vested	(45)	219.06
Restricted share units at July 31, 2023	70	$	232.88

As of July 31, 2023, there was $10,080 of remaining expense to be recognized related to outstanding restricted share units, which is expected to be recognized over a weighted average period of 1.8 years. The amount charged to expense related to restricted share units during each of the three months ended July 31, 2023 and 2022 was $2,152 and $2,154, respectively, compared to $6,658 and $6,246 for the nine months ended July 31, 2023 and 2022, respectively.

Performance Share Incentive Awards

Executive officers and selected other key employees are eligible to receive common share-based incentive awards. Payouts, in the form of unrestricted common shares, vary based on the degree to which corporate financial performance exceeds predetermined threshold, target and maximum performance goals over three-year performance periods. No payout will occur unless threshold performance is achieved.

The amount of compensation expense is based upon current performance projections and the percentage of the requisite service that has been rendered. The calculations are based upon the grant date fair value, which is principally driven by the stock price on the date of grant or a Monte Carlo valuation for awards with market conditions. The per share values were $231.34, $211.25 and $214.51 in 2023, and $260.60, $273.50 and $221.94 for 2022. The amount charged to expense related to performance awards for the three months ended July 31, 2023 and 2022 was $1,831 and $3,555, respectively, compared to charges of $4,785 and $10,296 for the nine months ended July 31, 2023 and 2022, respectively. As of July 31, 2023, there was $7,947 of unrecognized compensation cost related to performance share incentive awards.

Deferred Compensation

Our executive officers and other highly compensated employees may elect to defer up to 100% of their base pay and cash incentive compensation, and for executive officers, up to 90% of their share-based performance incentive payout each year. Additional share units are credited for quarterly dividends paid on our common shares. Expense related to dividends paid under this plan for the three months ended July 31, 2023 and 2022 was $30 and $17, respectively, compared to $77 and $53 for the nine months ended July 31, 2023 and 2022, respectively.

Deferred Directors' Compensation

Non-employee directors may defer all or part of their cash and equity-based compensation until retirement. Cash compensation may be deferred as cash or as share equivalent units. Deferred cash amounts are recorded as liabilities, and share equivalent units are recorded as equity. Additional share equivalent units are earned when common share dividends are declared.

The following table summarizes activity related to director deferred compensation share equivalent units during the nine months ended July 31, 2023:

	Number of Shares	Weighted-Average Grant Date Fair Value
Outstanding at October 31, 2022	90	$	77.70
Distributions	(13)	52.50
Outstanding at July 31, 2023	78	$	84.02

The amount charged to expense related to director deferred compensation for the three months ended July 31, 2023 and 2022 was $76 and $73, respectively, compared to $234 and $224 for the nine months ended July 31, 2023 and 2022, respectively.

XML

Warranties

9 Months Ended

Jul. 31, 2023

Guarantees [Abstract]

Warranties

Warranties

We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions is adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheets.  

Following is a reconciliation of the product warranty liability for the nine months ended July 31, 2023 and 2022:

	July 31, 2023		July 31, 2022
Beginning balance at October 31	$	11,723	$	11,113
Accruals for warranties	14,938		12,496
Warranty payments	(12,939)		(10,704)
Currency effect	566		(676)
Ending balance	$	14,288	$	12,229

XML

Operating segments

9 Months Ended

Jul. 31, 2023

Segment Reporting [Abstract]

Operating segments

Operating segments

We conduct business in three primary operating segments: Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions. The composition of segments and measure of segment profitability is consistent with that used by our chief operating decision maker. The primary measure used by the chief operating decision maker for purposes of making decisions about allocating resources to the segments and assessing performance is operating profit, which equals sales less cost of sales and certain operating expenses. Items below the operating profit line of the Condensed Consolidated Statements of Income (interest and investment income, interest expense and other income/expense) are excluded from the measure of segment profitability reviewed by our chief operating decision maker and are not presented by operating segment. The accounting policies of the segments are the same as those described in the Significant accounting policies Note.

Industrial Precision Solutions: This segment focuses on delivering proprietary dispensing and processing technology, both standard and highly customized equipment, to diverse end markets. Product lines commonly reduce material consumption, increase line efficiency through precision dispense and measurement and control, and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This segment primarily serves the industrial, consumer durables and non-durables markets.

Medical and Fluid Solutions: This segment includes the Company’s fluid management solutions for medical, high-tech industrial and other diverse end markets. Related plastic tubing, balloons, catheters, syringes, cartridges, tips and fluid connection components are used to dispense or control fluids within customers’ medical devices or products, as well as production processes.

Advanced Technology Solutions: This segment focuses on products serving electronics end markets. Advanced Technology Solutions products integrate our proprietary product technologies found in progressive stages of an electronics customer’s production processes, such as surface treatment, precisely controlled dispensing of material and test and inspection to ensure quality and reliability. Applications include, but are not limited to, semiconductors, printed circuit boards, electronic components and automotive electronics.

The following table presents information about our segments:

Three Months Ended	Industrial Precision Solutions		Medical and Fluid Solutions		Advanced Technology Solutions		Corporate		Total
July 31, 2023
Net external sales	$	338,257	$	170,871	$	139,549	$	—	$	648,677
Operating profit (loss)	115,346		54,019		27,083		(25,452)		170,996
July 31, 2022
Net external sales	$	341,215	$	177,840	$	143,073	$	—	$	662,128
Operating profit (loss)	119,706		58,103		28,155		(21,046)		184,918
Nine Months Ended
July 31, 2023
Net external sales	$	985,610	$	491,683	$	432,026	$	—	$	1,909,319
Operating profit (loss)	329,439		141,326		70,136		(53,179)		487,722
July 31, 2022
Net external sales	$	981,582	$	508,836	$	416,279	$	—	$	1,906,697
Operating profit (loss)	324,089		165,510		95,533		(60,381)		524,751

We had significant sales in the following geographic regions:

	Three Months Ended				Nine Months Ended
	July 31, 2023		July 31, 2022		July 31, 2023		July 31, 2022
Americas	$	290,515	$	279,205	$	834,125	$	792,859
Europe	167,536		151,659		498,379		479,900
Asia Pacific	190,626		231,264		576,815		633,938
Total net external sales	$	648,677	$	662,128	$	1,909,319	$	1,906,697

XML

Fair value measurements

9 Months Ended

Jul. 31, 2023

Fair Value Disclosures [Abstract]

Fair value measurements

Fair value measurements

The inputs to the valuation techniques used to measure fair value are classified into the following categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis:

July 31, 2023	Total		Level 1		Level 2		Level 3
Assets:
Foreign currency forward contracts (a)	$	9,608	$	—	$	9,608	$	—
Net investment contracts (b)	3,036		—		3,036		—
Total assets at fair value	$	12,644	$	—	$	12,644	$	—
Liabilities:
Deferred compensation plans (c)	$	10,636	$	—	$	10,636	$	—
Foreign currency forward contracts (a)	4,209		—		4,209		—
Net investment contracts (b)	4,601		—		4,601		—
Total liabilities at fair value	$	19,446	$	—	$	19,446	$	—

October 31, 2022	Total		Level 1		Level 2		Level 3
Assets:
Foreign currency forward contracts (a)	$	5,035	$	—	$	5,035	$	—
Total assets at fair value	$	5,035	$	—	$	5,035	$	—
Liabilities:
Deferred compensation plans (b)	$	9,076	$	—	$	9,076	$	—
Foreign currency forward contracts (a)	11,724		—		11,724		—
Total liabilities at fair value	$	20,800	$	—	$	20,800	$	—

(a)We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges.

(b)Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. The notional amount of our net investment hedge contracts as of July 31, 2023 was $385,000.

(c)Executive officers and other highly compensated employees may defer up to 100% of their salary and annual cash incentive compensation and for executive officers, up to 90% of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.

The carrying amounts and fair values of financial instruments, other than cash and cash equivalents, receivables, and accounts payable, are shown in the table below. The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments.

	July 31, 2023
	Carrying Amount		Fair Value
Long-term debt (including current portion)	$	838,098	$	836,098

Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy. The carrying amount of long-term debt is shown net of unamortized debt issuance costs as disclosed in the Long-term Debt Note.

XML

Derivative financial instruments

9 Months Ended

Jul. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative financial instruments

Derivative financial instruments  

Foreign Currency Forward Contracts

We operate internationally and enter into intercompany transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. Accordingly, the changes in the fair value of the foreign currency forward contracts are recognized in each accounting period in “Other – net” on the Condensed Consolidated Statements of Income together with the transaction gain or loss from the related balance sheet position.

For the three months ended July 31, 2023, we recognized a net loss of $93 on foreign currency forward contracts and a net loss of $885 from the change in fair value of balance sheet positions. For the three months ended July 31, 2022, we recognized a net gain of $15,181 on foreign currency forward contracts and a net loss of $14,436 from the change in fair value of balance sheet positions. For the nine months ended July 31, 2023, we recognized a net gain of $12,086 on foreign currency forward contracts and a net loss of $19,710 from the change in fair value of balance sheet positions. For the nine months ended July 31, 2022, we recognized a net gain of $2,503 on foreign currency forward contracts and a net loss of $394 from the change in fair value of balance sheet positions. The fair values of our foreign currency forward contract assets and liabilities are included in Receivable-net and Accrued liabilities, respectively, in our Consolidated Balance Sheets.

The following table summarizes, by currency, the foreign currency forward contracts outstanding at July 31, 2023 and 2022:

July 31, 2023 contract amounts:	Notional Sell Amounts		Notional Buy Amounts
Euro	$	95,064	$	194,850
British pound	20,489		132,956
Japanese yen	23,195		17,908
Mexican Peso	3,227		28,158
Hong Kong dollar	2,080		7,265
Singapore dollar	60		19,817
Australian dollar	—		9,236
Taiwan Dollar	—		8,000
Others	2,602		71,830
Total	$	146,717	$	490,020
July 31, 2022 contract amounts:	Notional Sell Amounts		Notional Buy Amounts
Euro	$	88,275	$	333,285
British pound	36,779		78,942
Japanese yen	16,688		37,163
Hong Kong dollar	—		67,341
Singapore dollar	378		18,025
Australian dollar	278		9,426
Others	26,012		98,113
Total	$	168,410	$	642,295

We are exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments. These financial instruments include cash deposits and foreign currency forward contracts. We periodically monitor the credit ratings of these counterparties in order to minimize our exposure. Our customers represent a wide variety of industries and geographic regions. For the three and nine months ended July 31, 2023 and 2022, there were no significant concentrations of credit risk.

Net Investment Hedges

Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We may utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries.

During the second quarter of 2023, the Company designated €180,000 of borrowings as a hedge of our net investment in certain foreign subsidiaries to mitigate the foreign exchange risk associated with certain investments in these subsidiaries. On June 30, 2023, the hedge was terminated. Any increase or decrease related to the remeasurement of the €180,000 borrowing into U.S. dollars was recorded in the currency translation component of Accumulated other comprehensive income (loss) within Shareholders' Equity in the Consolidated Balance Sheet. A gain of $1,144, net of tax, and a loss of $2,467, net of tax, was recorded on these net investment hedges for the three and nine months ended July 31, 2023, respectively.

During the quarter ended July 31, 2023, the Company entered into various cross currency swaps between the U.S. Dollar and Euro, Japanese Yen, Taiwan Dollar and Chinese Yuan which were designated as a hedges of our net investments in certain foreign subsidiaries to mitigate the foreign exchange risk associated with certain investments in these subsidiaries. Any increases or decreases related to the remeasurement of the hedges are recorded in the currency translation component of Accumulated other comprehensive income (loss) within Shareholders' Equity in the Consolidated Balance Sheet until the sale or substantial liquidation of the underlying investments. A loss of $1,205, net of tax, was recorded for both the three and nine months ended July 31, 2023.

The following table summarizes the fair values of our net investment contracts designated as net investment hedges in the Company's Consolidated Balance Sheets as of July 31, 2023:

	Prepaid expenses and other current assets		Other assets		Accrued liabilities		Other long-term liabilities
Net investment contracts	$	2,977	$	59	$	841	$	3,760

XML

Long-term debt

9 Months Ended

Jul. 31, 2023

Debt Disclosure [Abstract]

Long-term debt

Long-term debt

A summary of long-term debt is as follows:

	July 31, 2023		October 31, 2022
Revolving credit agreement, due 2028	$	200,000	$	—
Senior notes, due 2023-2025	32,000		55,500
Senior notes, due 2023-2027	54,286		71,429
Senior notes, due 2023-2030	260,000		350,000
Term loan due 2026	300,000		—
Euro Loan	—		261,893
	846,286		738,822
Less current maturities and notes payable	110,643		392,537
Less unamortized debt issuance costs	8,188		965
Long-term maturities	$	727,455	$	345,320

Revolving credit agreement, due 2028 — In June 2023, we entered into a $1,150,000 unsecured multi-currency credit facility with a group of banks, which provides for a term loan facility in the aggregate principal amount of $300,000 (the "Term Loan Facility"), maturing in June 2026, and a multicurrency revolving credit facility in the aggregate principal amount of $850,000 (the "Revolving Facility"), maturing in June 2028 (the "New Credit Agreement"). The Company borrowed and has outstanding $300,000 on the Term Loan Facility on June 6, 2023. The Revolving Facility permits borrowing in U.S. Dollars, Euros, Sterling, Swiss Francs, Singapore Dollars, Yen, and each other currency approved by a Revolving Facility lender. The New Credit Agreement provides that the applicable margin for (i) RFR, as defined in the New Credit Agreement, and Eurodollar Loans will range from 0.85% to 1.20% and (ii) Base Rate Loans will range from 0.00% to 0.20%, in each case, based on the Company’s Leverage Ratio (as defined in the Credit Agreement and calculated on a consolidated net debt basis). Borrowings under the New Credit Agreement bear interest at (i) either a base rate or a SOFR rate, with respect to borrowings in U.S. dollars, (ii) a eurocurrency rate, with respect to borrowings in Euros and Yen, or (iii) Daily Simple RFR, with respect to borrowings in Sterling, Swiss Francs or Singapore Dollars, plus, in each case, an applicable margin (and, solely in the case of Singapore Dollars, a spread adjustment). The applicable margin is based on the Company’s Leverage Ratio. The weighted-average interest rate at July 31, 2023 was 6.00%.

Revolving credit agreement, due 2024 — In April 2019, we entered into a $850,000 unsecured multi-currency credit facility with a group of banks, which amended, restated and extended our then existing syndicated revolving credit agreement. This facility had a five-year term expiring in April 2024 and included a $75,000 subfacility for swing-line loans. On April 17, 2023, we entered into an amendment to, among other things, replace LIBOR with SOFR, EURIBOR, SONIA and TIBOR for U.S. Dollar, Euro, British Pound Sterling and Japanese Yen borrowings, respectively. On June 6, 2023, this credit agreement was terminated and replaced by the New Credit Agreement.

Senior notes, due 2023-2025 — These unsecured fixed-rate notes entered into in 2012 with a group of insurance companies have a remaining weighted-average life of 1.25 years. The weighted-average interest rate at July 31, 2023 was 3.10%.

Senior notes, due 2023-2027 — These unsecured fixed-rate notes entered into in 2015 with a group of insurance companies have a remaining weighted-average life of 2.23 years. The weighted-average interest rate at July 31, 2023 was 3.11%.

Senior notes, due 2023-2030 — These unsecured fixed-rate notes entered into in 2018 with a group of insurance companies have a remaining weighted-average life of 3.13 years. The weighted-average interest rate at July 31, 2023 was 3.97%.  

Euro loan — The euro term loan facility with Bank of America Merrill Lynch International Limited was due in March 2023 and was repaid.

We were in compliance with all covenants at July 31, 2023, and the amount we could borrow would not have been limited by any debt covenants.

XML

Contingencies

9 Months Ended

Jul. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Contingencies

Contingencies

We are involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee and other matters arising from the normal course of business.  Including the environmental matters discussed below, after consultation with legal counsel, we do not believe that losses in excess of the amounts we have accrued would have a material adverse effect on our financial condition, quarterly or annual operating results or cash flows.

Environmental

We have voluntarily agreed with the City of New Richmond, Wisconsin and other potentially responsible parties to share costs associated with the remediation of the City of New Richmond municipal landfill (the Site) and the construction of a potable water delivery system serving the impacted area down gradient of the Site. As of July 31, 2023 and October 31, 2022, our accrual for the ongoing operation, maintenance and monitoring obligation at the Site was $266 and $266, respectively. The liability for environmental remediation represents management’s best estimate of the probable and reasonably estimable undiscounted costs related to known remediation obligations. The accuracy of our estimate of environmental liability is affected by several uncertainties such as additional requirements that may be identified in connection with remedial activities, the complexity and evolution of environmental laws and regulations, and the identification of presently unknown remediation requirements. Consequently, our liability could be greater than our current estimate. However, we do not expect that the costs associated with remediation will have a material adverse effect on our financial condition or results of operations.

XML

Subsequent Events

9 Months Ended

Jul. 31, 2023

Subsequent Events [Abstract]

Subsequent Events

Subsequent Event

On August 24, 2023, the Company completed the acquisition of the ARAG Group and its subsidiaries (ARAG Group or ARAG) pursuant to the terms of the Sale and Purchase Agreement, dated as of June 25, 2023, by and among the Company, its Italian subsidiary, Capvis Equity V LP (Capvis), DRIP Co-Investment (DRIP), and certain individuals (the Individual Sellers, and together with Capvis and DRIP, collectively, the Sellers). ARAG is a global market and innovation leader in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. ARAG will operate as a division of our Industrial Precision Solutions segment. In anticipation of the acquisition, the Company entered into a €760,000 senior unsecured term loan facility with a group of banks in August 2023 (the Term Facility). The Term Facility has a 364-day term and matures in August 2024, and loans under the facility bear interest at a eurocurrency rate plus an applicable margin that will range from 1.1250% to 1.625% based on the Company’s Leverage Ratio (as defined in the term loan credit agreement and calculated on a consolidated net debt basis). The all-cash ARAG acquisition of approximately €957,000, net of the repayment of approximately €30,300 of debt of the acquired companies, was funded using the Term Facility and Revolving Facility. The financial results of the ARAG Group acquisition are not expected to have a material impact on our Consolidated Financial Statements.

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Jul. 31, 2023	Apr. 30, 2023	Jan. 31, 2023	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Pay vs Performance Disclosure
Net income	$ 127,891	$ 127,563	$ 104,261	$ 141,811	$ 109,634	$ 120,409	$ 359,715	$ 371,854

XML

Insider Trading Arrangements - Stephen P. Lovass [Member]	9 Months Ended
	Jul. 31, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On June 30, 2023, Stephen P. Lovass, an Executive Vice President of the Company, adopted a trading arrangement for the sale of the Company’s common shares (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Lovass’s Rule 10b5-1 Trading Plan, which expires no later than March 28, 2024, provides for the sale of up to 6,898 common shares pursuant to the terms of the Rule 10b5-1 Trading Plan.
Name	Stephen P. Lovass
Title	Executive Vice President of the Company
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 30, 2023
Aggregate Available	6,898

XML

Significant accounting policies (Policies)

9 Months Ended

Jul. 31, 2023

Accounting Policies [Abstract]

Basis of presentation

Basis of presentation.  The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles in the United States (U.S. GAAP) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine months ended July 31, 2023 are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the Consolidated Financial Statements and notes included in our Annual Report on Form 10-K for the year ended October 31, 2022.

Consolidation

Consolidation.  The Condensed Consolidated Financial Statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50% or less or in which we do not have control but have the ability to exercise significant influence, are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.

Use of estimates

Use of estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements.  Actual amounts could differ from these estimates.

Revenue recognition

Revenue recognition. A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. Revenue for undelivered items is deferred and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of July 31, 2023 and 2022 were not material.

However, for certain contracts related to the sale of customer-specific products within our Medical and Fluid Solutions segment, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled and we are contractually entitled to payment for work performed to date plus a reasonable margin.  

As control transfers over time, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material on July 31, 2023 and October 31, 2022. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues at July 31, 2023 and October 31, 2022.

Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services.  Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred as the amortization period resulting from capitalizing the

costs is one year or less. These costs are recorded within Selling and administrative expenses in our Condensed Consolidated Statements of Income.

We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and are not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and, therefore, these items are typically regarded as inconsequential or not material.

We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to our Operating segments Note for details.

Earnings per share

Earnings per share.  Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted shares and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options excluded from the calculation of diluted earnings per share for the three months ended July 31, 2023 and 2022 were 138 and 76, respectively. Options excluded from the calculation of diluted earnings per share for the nine months ended July 31, 2023 and 2022 were 141 and 79, respectively.

Recently issued accounting standards

There have been no new accounting standards issued which would require either disclosure or adoption during the current periods.

XML

Business Combinations and Asset Acquisitions (Tables)

Nov. 03, 2022

Business Combination and Asset Acquisition [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The assets and liabilities acquired were as follows:

	November 3, 2022
Cash	$	40,890
Receivables - net	21,364
Inventories - net	35,300
Goodwill	279,630
Intangibles	58,600
Other assets	14,046
Total Assets	$	449,830
Accounts payable	$	8,109
Deferred income taxes	14,294
Other liabilities	8,694
Total Liabilities	$	31,097

XML

Inventories (Tables)

9 Months Ended

Jul. 31, 2023

Inventory Disclosure [Abstract]

Schedule of Inventories

Components of inventories were as follows:

	July 31, 2023		October 31, 2022
Finished goods	$	234,690	$	218,491
Raw materials and component parts	200,475		157,447
Work-in-process	62,856		53,195
	498,021		429,133
Obsolescence and other reserves	(58,280)		(45,735)
	$	439,741	$	383,398

XML

Property, Plant and Equipment (Tables)

9 Months Ended

Jul. 31, 2023

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

Components of property, plant and equipment were as follows:

	July 31, 2023		October 31, 2022
Land	$	9,856	$	9,278
Land improvements	5,033		4,979
Buildings	282,260		271,450
Machinery and equipment	536,215		505,343
Enterprise management system	52,938		52,513
Construction-in-progress	20,130		31,466
Leased property under finance leases	28,047		27,512
	934,479		902,541
Accumulated depreciation and amortization	(583,744)		(549,099)
	$	350,735	$	353,442

XML

Goodwill and other intangible assets (Tables)

9 Months Ended

Jul. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Changes in Carrying Amount of Goodwill

Changes in the carrying amount of goodwill for the nine months ended July 31, 2023 by operating segment were as follows:

	Industrial Precision Solutions		Medical Fluid Systems		Advanced Technology Solutions		Total
Balance at October 31, 2022	$	520,236	$	1,172,069	$	112,388	$	1,804,693
Acquisitions	—		—		279,630		279,630
Currency effect	4,744		3,869		17,844		26,457
Balance at July 31, 2023	$	524,980	$	1,175,938	$	409,862	$	2,110,780

Summary of Intangible Assets Subject to Amortization

Information regarding our intangible assets subject to amortization was as follows:

	July 31, 2023
	Carrying  Amount		Accumulated Amortization		Net Book  Value
Customer relationships	$	517,147	$	282,598	$	234,549
Patent/technology costs	176,396		109,783		66,613
Trade name	99,413		50,673		48,740
Non-compete agreements	10,559		9,937		622
Other	143		143		—
Total	$	803,658	$	453,134	$	350,524
	October 31, 2022
	Carrying  Amount		Accumulated Amortization		Net Book  Value
Customer relationships	$	480,058	$	250,798	$	229,260
Patent/technology costs	157,549		96,426		61,123
Trade name	82,759		44,707		38,052
Non-compete agreements	10,253		9,290		963
Other	446		442		4
Total	$	731,065	$	401,663	$	329,402

XML

Pension and other postretirement plans (Tables)

9 Months Ended

Jul. 31, 2023

Retirement Benefits [Abstract]

Components of Net Periodic Benefits Cost

The components of net periodic pension and other postretirement cost for the three and nine months ended July 31, 2023 and 2022 were:

	U.S.				International
Three Months Ended	2023		2022		2023		2022
Service cost	$	2,744	$	3,423	$	281	$	423
Interest cost	4,176		3,322		642		272
Expected return on plan assets	(6,529)		(5,692)		(392)		(347)
Amortization of prior service cost (credit)	—		12		(13)		(13)
Amortization of net actuarial loss	—		1,197		20		558
Total benefit cost	$	391	$	2,262	$	538	$	893
	U.S.				International
Nine Months Ended	2023		2022		2023		2022
Service cost	$	8,233	$	13,338	$	838	$	1,343
Interest cost	12,526		11,146		1,887		861
Expected return on plan assets	(19,587)		(22,082)		(1,151)		(1,109)
Amortization of prior service cost (credit)	—		36		(38)		(43)
Amortization of net actuarial loss	—		6,282		61		1,758
Settlement loss	—		41,221		—		—
Total benefit cost	$	1,172	$	49,941	$	1,597	$	2,810

The components of other postretirement benefit costs for the three and nine months ended July 31, 2023 and 2022 were:

	U.S.				International
Three Months Ended	2023		2022		2023		2022
Service cost	$	100	$	172	$	1	$	3
Interest cost	766		481		3		3
Amortization of net actuarial (gain) loss	—		244		(16)		(12)
Total benefit cost (income)	$	866	$	897	$	(12)	$	(6)
	U.S.				International
Nine Months Ended	2023		2022		2023		2022
Service cost	$	299	$	515	$	4	$	9
Interest cost	2,297		1,443		8		10
Amortization of net actuarial (gain) loss	—		733		(47)		(37)
Total benefit cost (income)	$	2,596	$	2,691	$	(35)	$	(18)

XML

Accumulated other comprehensive loss (Tables)

9 Months Ended

Jul. 31, 2023

Equity [Abstract]

Summary of Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive income (loss), including adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below.

	Cumulative translation adjustments		Pension and postretirement  benefit plan adjustments		Accumulated other  comprehensive income (loss)
Balance at October 31, 2022	$	(160,046)	$	(47,736)	$	(207,782)
Pension and other postretirement plan adjustments, net of tax of ($305)	—		(908)		(908)
Foreign currency translation adjustments (a)	79,986		—		79,986
Balance at July 31, 2023	$	(80,060)	$	(48,644)	$	(128,704)

(a) Includes a net loss of $3,672, net of tax of $1,097, on net investment hedges.

XML

Stock-based compensation (Tables)

9 Months Ended

Jul. 31, 2023

Share-Based Payment Arrangement [Abstract]

Summarized Activity Related to Stock Options

The following table summarizes activity related to stock options for the nine months ended July 31, 2023:

	Number of Options	Weighted- Average Exercise Price  Per Share		Aggregate Intrinsic Value		Weighted Average Remaining Term
Outstanding at October 31, 2022	1,187	$	141.82
Granted	80	239.44
Exercised	(163)	115.67
Forfeited or expired	(10)	206.93
Outstanding at July 31, 2023	1,094	$	151.09	$	111,165	5.1 years
Expected to vest	245	$	214.42	$	10,006	7.5 years
Exercisable at July 31, 2023	846	$	132.58	$	101,014	4.4 years

Fair Value Assumptions of Stock Options

The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Nine Months Ended	July 31, 2023			July 31, 2022
Expected volatility	30.4%	-	31.8%	30.6%	-	30.8%
Expected dividend yield	1.12%	-	1.27%	0.76%	-	0.76%
Risk-free interest rate	3.79%	-	4.21%	1.36%	-	1.47%
Expected life of the option (in years)	5.0	-	6.2	5.3	-	6.2

Summarized Activity Related to Restricted Stock

The following table summarizes activity related to restricted shares during the nine months ended July 31, 2023:

	Number of Shares	Weighted-Average Grant Date Fair Value
Restricted shares at October 31, 2022	6	$	167.99
Vested	(6)	167.99
Restricted shares at July 31, 2023	—	$	—

Summarized Activity Related to Restricted Stock Units

The following table summarizes activity related to restricted share units during the nine months ended July 31, 2023:

	Number of Units	Weighted-Average Grant Date Fair Value
Restricted share units at October 31, 2022	81	$	223.77
Granted	39	237.18
Forfeited	(5)	241.37
Vested	(45)	219.06
Restricted share units at July 31, 2023	70	$	232.88

Summarized Activity Related to Director Deferred Compensation Shares

The following table summarizes activity related to director deferred compensation share equivalent units during the nine months ended July 31, 2023:

	Number of Shares	Weighted-Average Grant Date Fair Value
Outstanding at October 31, 2022	90	$	77.70
Distributions	(13)	52.50
Outstanding at July 31, 2023	78	$	84.02

XML

Warranties (Tables)

9 Months Ended

Jul. 31, 2023

Guarantees [Abstract]

Reconciliation of Product Warranty Liability

Following is a reconciliation of the product warranty liability for the nine months ended July 31, 2023 and 2022:

	July 31, 2023		July 31, 2022
Beginning balance at October 31	$	11,723	$	11,113
Accruals for warranties	14,938		12,496
Warranty payments	(12,939)		(10,704)
Currency effect	566		(676)
Ending balance	$	14,288	$	12,229

XML

Operating segments (Tables)

9 Months Ended

Jul. 31, 2023

Segment Reporting [Abstract]

Schedule of Segments

The following table presents information about our segments:

Three Months Ended	Industrial Precision Solutions		Medical and Fluid Solutions		Advanced Technology Solutions		Corporate		Total
July 31, 2023
Net external sales	$	338,257	$	170,871	$	139,549	$	—	$	648,677
Operating profit (loss)	115,346		54,019		27,083		(25,452)		170,996
July 31, 2022
Net external sales	$	341,215	$	177,840	$	143,073	$	—	$	662,128
Operating profit (loss)	119,706		58,103		28,155		(21,046)		184,918
Nine Months Ended
July 31, 2023
Net external sales	$	985,610	$	491,683	$	432,026	$	—	$	1,909,319
Operating profit (loss)	329,439		141,326		70,136		(53,179)		487,722
July 31, 2022
Net external sales	$	981,582	$	508,836	$	416,279	$	—	$	1,906,697
Operating profit (loss)	324,089		165,510		95,533		(60,381)		524,751

Sales and Long-lived Asset Information by Geographic Regions

We had significant sales in the following geographic regions:

	Three Months Ended				Nine Months Ended
	July 31, 2023		July 31, 2022		July 31, 2023		July 31, 2022
Americas	$	290,515	$	279,205	$	834,125	$	792,859
Europe	167,536		151,659		498,379		479,900
Asia Pacific	190,626		231,264		576,815		633,938
Total net external sales	$	648,677	$	662,128	$	1,909,319	$	1,906,697

XML

Fair value measurements (Tables)

9 Months Ended

Jul. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis

The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis:

July 31, 2023	Total		Level 1		Level 2		Level 3
Assets:
Foreign currency forward contracts (a)	$	9,608	$	—	$	9,608	$	—
Net investment contracts (b)	3,036		—		3,036		—
Total assets at fair value	$	12,644	$	—	$	12,644	$	—
Liabilities:
Deferred compensation plans (c)	$	10,636	$	—	$	10,636	$	—
Foreign currency forward contracts (a)	4,209		—		4,209		—
Net investment contracts (b)	4,601		—		4,601		—
Total liabilities at fair value	$	19,446	$	—	$	19,446	$	—

October 31, 2022	Total		Level 1		Level 2		Level 3
Assets:
Foreign currency forward contracts (a)	$	5,035	$	—	$	5,035	$	—
Total assets at fair value	$	5,035	$	—	$	5,035	$	—
Liabilities:
Deferred compensation plans (b)	$	9,076	$	—	$	9,076	$	—
Foreign currency forward contracts (a)	11,724		—		11,724		—
Total liabilities at fair value	$	20,800	$	—	$	20,800	$	—

(a)We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges.

(b)Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. The notional amount of our net investment hedge contracts as of July 31, 2023 was $385,000.

(c)Executive officers and other highly compensated employees may defer up to 100% of their salary and annual cash incentive compensation and for executive officers, up to 90% of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.

Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable

The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments.

	July 31, 2023
	Carrying Amount		Fair Value
Long-term debt (including current portion)	$	838,098	$	836,098

XML

Derivative financial instruments (Tables) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

Jul. 31, 2023

Jul. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Outstanding Currency, Forward Exchange Contracts

The following table summarizes, by currency, the foreign currency forward contracts outstanding at July 31, 2023 and 2022:

July 31, 2023 contract amounts:	Notional Sell Amounts		Notional Buy Amounts
Euro	$	95,064	$	194,850
British pound	20,489		132,956
Japanese yen	23,195		17,908
Mexican Peso	3,227		28,158
Hong Kong dollar	2,080		7,265
Singapore dollar	60		19,817
Australian dollar	—		9,236
Taiwan Dollar	—		8,000
Others	2,602		71,830
Total	$	146,717	$	490,020
July 31, 2022 contract amounts:	Notional Sell Amounts		Notional Buy Amounts
Euro	$	88,275	$	333,285
British pound	36,779		78,942
Japanese yen	16,688		37,163
Hong Kong dollar	—		67,341
Singapore dollar	378		18,025
Australian dollar	278		9,426
Others	26,012		98,113
Total	$	168,410	$	642,295

Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location

The following table summarizes the fair values of our net investment contracts designated as net investment hedges in the Company's Consolidated Balance Sheets as of July 31, 2023:

	Prepaid expenses and other current assets		Other assets		Accrued liabilities		Other long-term liabilities
Net investment contracts	$	2,977	$	59	$	841	$	3,760

Net Investment Hedge Gain (Loss)

$ (1,205)

Other Comprehensive Income (Loss), Net Investment Hedge, Net of Tax

$ 1,144

$ (2,467)

XML

Long-term debt (Tables)

9 Months Ended

Jul. 31, 2023

Debt Disclosure [Abstract]

Long-Term Debt

A summary of long-term debt is as follows:

	July 31, 2023		October 31, 2022
Revolving credit agreement, due 2028	$	200,000	$	—
Senior notes, due 2023-2025	32,000		55,500
Senior notes, due 2023-2027	54,286		71,429
Senior notes, due 2023-2030	260,000		350,000
Term loan due 2026	300,000		—
Euro Loan	—		261,893
	846,286		738,822
Less current maturities and notes payable	110,643		392,537
Less unamortized debt issuance costs	8,188		965
Long-term maturities	$	727,455	$	345,320

XML

Significant accounting policies - Additional Information (Detail) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Significant Accounting Policies [Line Items]
Less than 50% Ownership Percentage, Accounted for under the Equity Method of Investment	50.00%		50.00%
Stock Options
Significant Accounting Policies [Line Items]
Options for common shares excluded from computation of diluted earning per share (in shares)	138	76	141	79

XML

Acquisitions - Narrative (Detail) - USD ($) $ in Thousands			9 Months Ended
	Nov. 03, 2022	Nov. 01, 2021	Jul. 31, 2023	Jul. 31, 2022	Oct. 31, 2022
Business Acquisition [Line Items]
Acquisition of businesses, net of cash acquired			$ 377,843	$ 171,613
Goodwill			$ 2,110,780		$ 1,804,693
NDC
Business Acquisition [Line Items]
Acquired percent of the outstanding shares		100.00%
Acquisition of businesses, net of cash acquired		$ 171,613
Cash		7,533
Goodwill		131,129
Intangibles		31,130
Other working capital adjustments		2,763
Goodwill, expected tax deductible amount		72,018
NDC | Trade name
Business Acquisition [Line Items]
Intangibles		$ 10,800
Intangible assets amortization period		13 years
NDC | Technology-Based Intangible Assets
Business Acquisition [Line Items]
Intangibles		$ 10,000
Intangible assets amortization period		7 years
NDC | Customer relationships
Business Acquisition [Line Items]
Intangibles		$ 9,500
Intangible assets amortization period		4 years
NDC | Non-compete agreements
Business Acquisition [Line Items]
Intangibles		$ 830
Intangible assets amortization period		3 years
CyberOptics Corporation
Business Acquisition [Line Items]
Acquired percent of the outstanding shares	100.00%
Acquisition of businesses, net of cash acquired	$ 377,843
Cash	40,890
Goodwill	279,630
Intangibles	58,600
CyberOptics Corporation | Trade name
Business Acquisition [Line Items]
Intangibles	$ 15,200
Intangible assets amortization period	15 years
CyberOptics Corporation | Technology-Based Intangible Assets
Business Acquisition [Line Items]
Intangibles	$ 14,600
Intangible assets amortization period	7 years
CyberOptics Corporation | Customer relationships
Business Acquisition [Line Items]
Intangibles	$ 28,800
Intangible assets amortization period	12 years

XML

Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Nov. 03, 2022	Jul. 31, 2023	Oct. 31, 2022
Business Acquisition [Line Items]
Goodwill		$ 2,110,780	$ 1,804,693
CyberOptics Corporation
Business Acquisition [Line Items]
Cash	$ 40,890
Receivables - net	21,364
Inventories - net	35,300
Goodwill	279,630
Intangibles	58,600
Other assets	14,046
Total Assets	449,830
Accounts payable	8,109
Deferred income taxes	14,294
Other liabilities	8,694
Total Liabilities	$ 31,097

XML

Receivables (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Oct. 31, 2022
Credit Loss [Abstract]
Accounts receivable, after allowance for credit loss	$ 8,076		$ 8,076		$ 8,218
Provisions for losses on receivables	$ 410	$ 788	$ (239)	$ 1,439

XML

Inventories - Schedule of Inventories (Detail) - USD ($) $ in Thousands	Jul. 31, 2023	Oct. 31, 2022
Inventory Disclosure [Abstract]
Finished goods	$ 234,690	$ 218,491
Raw materials and component parts	200,475	157,447
Work-in-process	62,856	53,195
Inventories - gross	498,021	429,133
Obsolescence and other reserves	(58,280)	(45,735)
Inventories - net	$ 439,741	$ 383,398

XML

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Oct. 31, 2022
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 934,479		$ 934,479		$ 902,541
Accumulated depreciation and amortization	(583,744)		(583,744)		(549,099)
Property, plant and equipment - net	350,735		350,735		353,442
Depreciation	13,180	$ 12,178	38,798	$ 36,876
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	9,856		9,856		9,278
Land improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	5,033		5,033		4,979
Buildings
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	282,260		282,260		271,450
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	536,215		536,215		505,343
Enterprise management system
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	52,938		52,938		52,513
Construction-in-progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	20,130		20,130		31,466
Leased property under finance leases
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 28,047		$ 28,047		$ 27,512

XML

Goodwill and other intangible assets - Summary of Changes in Carrying Amount of Goodwill (Detail) $ in Thousands	9 Months Ended
	Jul. 31, 2023 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 1,804,693
Acquisitions	279,630
Currency effect	26,457
Ending balance	2,110,780
Industrial Precision Solutions
Goodwill [Roll Forward]
Beginning balance	520,236
Acquisitions	0
Currency effect	4,744
Ending balance	524,980
Advanced Technology Solutions
Goodwill [Roll Forward]
Beginning balance	112,388
Acquisitions	279,630
Currency effect	17,844
Ending balance	409,862
Medical Fluid Systems
Goodwill [Roll Forward]
Beginning balance	1,172,069
Acquisitions	0
Currency effect	3,869
Ending balance	$ 1,175,938

XML

Goodwill and other intangible assets - Summary of Intangible Assets Subject to Amortization (Detail) - USD ($) $ in Thousands	Jul. 31, 2023	Oct. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	$ 803,658	$ 731,065
Accumulated Amortization	453,134	401,663
Net Book  Value	350,524	329,402
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	517,147	480,058
Accumulated Amortization	282,598	250,798
Net Book  Value	234,549	229,260
Patent/technology costs
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	176,396	157,549
Accumulated Amortization	109,783	96,426
Net Book  Value	66,613	61,123
Trade name
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	99,413	82,759
Accumulated Amortization	50,673	44,707
Net Book  Value	48,740	38,052
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	10,559	10,253
Accumulated Amortization	9,937	9,290
Net Book  Value	622	963
Other
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	143	446
Accumulated Amortization	143	442
Net Book  Value	$ 0	$ 4

XML

Goodwill and other intangible assets - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets, amortization expense	$ 13,922	$ 12,709	$ 41,839	$ 38,366

XML

Pension and other postretirement plans - Additional Information (Details) $ in Thousands	Jul. 31, 2022 USD ($) segment
Retirement Benefits [Abstract]
Defined benefit plan, plan assets, amount | $	$ 171,181
Number of retirees and other beneficiaries | segment	1,500

XML

Pension and other postretirement plans - Net Periodic Benefit Cost (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Pension Plans | International
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 281	$ 423	$ 838	$ 1,343
Interest cost	642	272	1,887	861
Expected return on plan assets	(392)	(347)	(1,151)	(1,109)
Amortization of prior service cost (credit)	(13)	(13)	(38)	(43)
Amortization of net actuarial (gain) loss	20	558	61	1,758
Total benefit cost	538	893	1,597	2,810
Settlement loss			0	0
Pension Plans | United States
Defined Benefit Plan Disclosure [Line Items]
Service cost	2,744	3,423	8,233	13,338
Interest cost	4,176	3,322	12,526	11,146
Expected return on plan assets	(6,529)	(5,692)	(19,587)	(22,082)
Amortization of prior service cost (credit)	0	12	0	36
Amortization of net actuarial (gain) loss	0	1,197	0	6,282
Total benefit cost	391	2,262	1,172	49,941
Settlement loss			0	(41,221)
Postretirement Benefit Costs | International
Defined Benefit Plan Disclosure [Line Items]
Service cost	1	3	4	9
Interest cost	3	3	8	10
Amortization of net actuarial (gain) loss	(16)	(12)	(47)	(37)
Total benefit cost	(12)	(6)	(35)	(18)
Postretirement Benefit Costs | United States
Defined Benefit Plan Disclosure [Line Items]
Service cost	100	172	299	515
Interest cost	766	481	2,297	1,443
Amortization of net actuarial (gain) loss	0	244	0	733
Total benefit cost	$ 866	$ 897	$ 2,596	$ 2,691

XML

Income taxes (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Effective tax rates	21.10%	21.40%	20.90%	21.20%
Income tax provision included discrete tax benefit due to share-based payment transactions	$ 996	$ 115	$ 2,745	$ 1,539

XML

Accumulated other comprehensive loss - Summary of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Jul. 31, 2023	Apr. 30, 2023	Jan. 31, 2023	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 2,497,002	$ 2,446,685	$ 2,294,375	$ 2,190,616	$ 2,218,628	$ 2,159,130	$ 2,294,375	$ 2,159,130
Pension and other postretirement plan adjustments, net of tax of ($305)	(159)			1,848			(908)	7,686
Foreign currency translation adjustments (a)	3,455	(290)	76,821	(21,220)	(46,901)	(13,358)	79,986	(81,479)
Ending balance	2,579,806	2,497,002	2,446,685	2,199,045	2,190,616	2,218,628	2,579,806	2,199,045
Amortization of prior service costs and net actuarial losses, tax							305
Other Comprehensive Income (Loss), Net Investment Hedge, Tax							1,097
Other Comprehensive Income (Loss), Net Investment Hedge, Net of Tax	1,144						(2,467)
Other Comprehensive Income (Loss), Net Investment Hedge, Gross							(3,672)
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(132,000)	(131,537)	(207,782)	(198,209)	(186,133)	(175,835)	(207,782)	(175,835)
Foreign currency translation adjustments (a)	3,455	(290)	76,821	(21,220)	(46,901)	(13,358)
Ending balance	(128,704)	$ (132,000)	(131,537)	$ (217,581)	$ (198,209)	$ (186,133)	(128,704)	$ (217,581)
Cumulative translation adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(160,046)				(160,046)
Pension and other postretirement plan adjustments, net of tax of ($305)							0
Foreign currency translation adjustments (a)							79,986
Ending balance	(80,060)						(80,060)
Pension and postretirement  benefit plan adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			$ (47,736)				(47,736)
Pension and other postretirement plan adjustments, net of tax of ($305)							(908)
Foreign currency translation adjustments (a)							0
Ending balance	$ (48,644)						$ (48,644)

XML

Stock-based compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum number of common shares authorized for grant (in shares)	900,000		900,000
Number of common shares available for grant (in shares)	2,012,000		2,012,000
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum			100.00%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum			90.00%
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option expiring period			10 years
Normal retirement age			65 years
Period for options considered to be forfeited for retirees			12 months
Termination period on death or disability of option holder			12 months
Compensation expense recognized	$ 1,697	$ 1,580	$ 4,982	$ 5,743
Unrecognized compensation cost related to unvested stock option	7,013		$ 7,013
Weighted average period expected to be amortized, non vested shares			1 year 8 months 12 days
Weighted-average expected volatility used			30.60%	30.60%
Weighted average grant date fair value of stock options granted (in dollars per share)			$ 77.99	$ 79.03
Total intrinsic value of options exercised	7,741	1,052	$ 19,873	$ 10,418
Cash received from the exercise of stock options			$ 18,449	8,845
Stock Options | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum rate of stock option			25.00%
Restricted Shares and Restricted Share Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant restricted shares transferred period			3 years
Restricted Shares and Restricted Share Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant restricted shares transferred period			1 year
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Normal retirement age			65 years
Period for restricted shares and share units considered to be forfeited for retirees			12 months
Restricted shares termination period for disability or death			12 months
Unrecognized compensation cost related to nonvested restricted stock	0		$ 0
Expense related to nonvested common shares	73	243	336	856
Common share dividends amount included in compensation cost	$ 2	4	$ 5	14
Weighted average grant date fair value (in dollars per share)	$ 0		$ 0		$ 167.99
Restricted Stock Unit
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period expected to be amortized, non vested shares			1 year 9 months 18 days
Unrecognized compensation cost related to nonvested restricted stock	$ 10,080		$ 10,080
Expense related to nonvested common shares	$ 2,152	2,154	$ 6,658	6,246
Weighted average grant date fair value (in dollars per share)	$ 232.88		$ 232.88		$ 223,770
Performance Share Incentive Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award requisite service period			3 years
Compensation expense	$ 1,831	$ 3,555	$ 4,785	$ 10,296
Unrecognized compensation cost	$ 7,947		$ 7,947
Performance Share Incentive Awards | Grant Date One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in dollars per share)	$ 231.34	$ 273.50	$ 231.34	$ 273.50
Performance Share Incentive Awards | Grant Date Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in dollars per share)	211.25	260.60	211.25	260.60
Performance Share Incentive Awards | Grant Date Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in dollars per share)	$ 214.51	$ 221.94	$ 214.51	$ 221.94
Deferred Compensation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common share dividends amount included in compensation cost	$ 30	$ 17	$ 77	$ 53
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum			100.00%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum			90.00%
Deferred Compensation | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expense related to director deferred compensation	$ 76	$ 73	$ 234	$ 224

XML

Stock-based compensation - Summarized Activity Related to Stock Options (Detail) - Stock Options $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Jul. 31, 2023 USD ($) $ / shares shares
Number of Options
Beginning balance (in shares) | shares	1,187
Granted (in shares) | shares	80
Exercised (in shares) | shares	(163)
Forfeited or expired (in shares) | shares	(10)
Ending balance (in shares) | shares	1,094
Expected to vest (in shares) | shares	245
Exercisable (in shares) | shares	846
Weighted- Average Exercise Price  Per Share
Beginning balance (in dollars per share) | $ / shares	$ 141.82
Granted (in dollars per share) | $ / shares	239.44
Exercised (in dollars per share) | $ / shares	115.67
Forfeited or expired (in dollars per share) | $ / shares	206.93
Ending balance (in dollars per share) | $ / shares	151.09
Expected to vest (in dollars per share) | $ / shares	214.42
Exercisable (in dollars per share) | $ / shares	$ 132.58
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Aggregate intrinsic value, outstanding | $	$ 111,165
Aggregate intrinsic value, expected to vest | $	10,006
Aggregate intrinsic value, exercisable | $	$ 101,014
Weighted average remaining term, outstanding	5 years 1 month 6 days
Weighted average remaining term, expected to vest	7 years 6 months
Weighted average remaining term, exercisable	4 years 4 months 24 days

XML

Stock-based compensation - Fair Value Assumptions of Stock Options (Detail) - Stock Options	9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility, minimum	30.40%	30.60%
Expected volatility, maximum	31.80%	30.80%
Risk-free interest rate, minimum	3.79%	1.36%
Risk-free interest rate, maximum	4.21%	1.47%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	1.12%	0.76%
Expected life of the option (in years)	5 years	5 years 3 months 18 days
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	1.27%	0.76%
Expected life of the option (in years)	6 years 2 months 12 days	6 years 2 months 12 days

XML

Stock-based compensation - Summarized Activity Related to Restricted Stock (Detail) - Restricted Stock shares in Thousands	9 Months Ended
	Jul. 31, 2023 $ / shares shares
Number of Shares
Beginning balance (in shares) | shares	6
Vested (in shares) | shares	(6)
Ending balance (in shares) | shares	0
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 167.99
Vested (in dollars per share) | $ / shares	167.99
Ending balance (in dollars per share) | $ / shares	$ 0

XML

Stock-based compensation - Summarized Activity Related to Restricted Stock Units (Detail) - Restricted Stock Unit shares in Thousands	9 Months Ended
	Jul. 31, 2023 $ / shares shares
Number of Shares
Beginning balance (in shares) | shares	81
Granted (in shares) | shares	39
Forfeited (in shares) | shares	(5)
Vested (in shares) | shares	(45)
Ending balance (in shares) | shares	70
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 223,770
Granted (in dollars per share) | $ / shares	237.18
Forfeited (in dollars per share) | $ / shares	241.37
Vested (in dollars per share) | $ / shares	219.06
Ending balance (in dollars per share) | $ / shares	$ 232.88

XML

Stock-based compensation - Summarized Activity Related to Director Deferred Compensation Shares (Detail) - Directors - Deferred Compensation Share Equivalent Units shares in Thousands	9 Months Ended
	Jul. 31, 2023 $ / shares shares
Number of Shares
Outstanding, Beginning balance (in shares) | shares	90
Distributions (in shares) | shares	(13)
Outstanding, Ending balance (in shares) | shares	78
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 77.70
Distributions (in dollars per share) | $ / shares	52.50
Ending balance (in dollars per share) | $ / shares	$ 84.02

XML

Warranties - Additional Information (Detail)	9 Months Ended
	Jul. 31, 2023
Guarantees [Abstract]
Product warranty period	1 year

XML

Warranties - Reconciliation of Product Warranty Liability (Detail) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]
Beginning balance	$ 11,723	$ 11,113
Accruals for warranties	14,938	12,496
Warranty payments	(12,939)	(10,704)
Currency effect	566	(676)
Ending balance	$ 14,288	$ 12,229

XML

Operating segments - Additional Information (Detail)	9 Months Ended
	Jul. 31, 2023 segment
Segment Reporting [Abstract]
Number of operating segments	3

XML

Operating segments - Segments (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Segment Reporting Information [Line Items]
Net external sales	$ 648,677	$ 662,128	$ 1,909,319	$ 1,906,697
Operating profit (loss)	170,996	184,918	487,722	524,751
Operating Segments
Segment Reporting Information [Line Items]
Net external sales	648,677	662,128	1,909,319	1,906,697
Operating profit (loss)	170,996	184,918	487,722	524,751
Operating Segments | Industrial Precision Solutions
Segment Reporting Information [Line Items]
Net external sales	338,257	341,215	985,610	981,582
Operating profit (loss)	115,346	119,706	329,439	324,089
Operating Segments | Advanced Technology Solutions
Segment Reporting Information [Line Items]
Net external sales	139,549	143,073	432,026	416,279
Operating profit (loss)	27,083	28,155	70,136	95,533
Operating Segments | Medical and Fluid Solutions
Segment Reporting Information [Line Items]
Net external sales	170,871	177,840	491,683	508,836
Operating profit (loss)	54,019	58,103	141,326	165,510
Corporate
Segment Reporting Information [Line Items]
Net external sales	0	0	0	0
Operating profit (loss)	$ (25,452)	$ (21,046)	$ (53,179)	$ (60,381)

XML

Operating segments - Sales Information by Geographic Regions (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Net external sales	$ 648,677	$ 662,128	$ 1,909,319	$ 1,906,697
Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Net external sales	290,515	279,205	834,125	792,859
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Net external sales	167,536	151,659	498,379	479,900
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net external sales	$ 190,626	$ 231,264	$ 576,815	$ 633,938

XML

Fair value measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Recurring - USD ($) $ in Thousands	Jul. 31, 2023	Oct. 31, 2022
Assets:
Foreign currency forward contracts	$ 9,608	$ 5,035
Net investment contracts	3,036
Total assets at fair value	12,644	5,035
Liabilities:
Deferred compensation plans	10,636	9,076
Foreign currency forward contracts	4,209	11,724
Net investment contracts	4,601
Total liabilities at fair value	19,446	20,800
Level 1
Assets:
Foreign currency forward contracts	0	0
Net investment contracts	0
Total assets at fair value	0	0
Liabilities:
Deferred compensation plans	0	0
Foreign currency forward contracts	0	0
Net investment contracts	0
Total liabilities at fair value	0	0
Level 2
Assets:
Foreign currency forward contracts	9,608	5,035
Net investment contracts	3,036
Total assets at fair value	12,644	5,035
Liabilities:
Deferred compensation plans	10,636	9,076
Foreign currency forward contracts	4,209	11,724
Net investment contracts	4,601
Total liabilities at fair value	19,446	20,800
Level 3
Assets:
Foreign currency forward contracts	0	0
Net investment contracts	0
Total assets at fair value	0	0
Liabilities:
Deferred compensation plans	0	0
Foreign currency forward contracts	0	0
Net investment contracts	0
Total liabilities at fair value	$ 0	$ 0

XML

Fair value measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Additional Information) (Detail) $ in Millions	9 Months Ended
	Jul. 31, 2023 USD ($)
Fair Value Disclosures [Abstract]
Notional Amounts of foreign currency derivative contracts	$ 385
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum	100.00%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum	90.00%

XML

Fair value measurements - Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable (Detail) $ in Thousands	Jul. 31, 2023 USD ($)
Fair Value Disclosures [Abstract]
Long-term debt, carrying amount	$ 838,098
Long-term debt, fair value	$ 836,098

XML

Derivative financial instruments - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Maturity of foreign currency forward contracts			90 days
Gains (losses) on foreign currency forward contracts	$ (93)	$ 15,181	$ 12,086	$ 2,503
Change in unrealized gain (loss) on foreign currency derivative instruments	(885)	$ (14,436)	(19,710)	$ (394)
Other Comprehensive Income (Loss), Net Investment Hedge, Net of Tax	$ 1,144		$ (2,467)

XML

Derivative financial instruments - Outstanding Currency, Forward Exchange Contracts (Detail) - USD ($) $ in Thousands	Jul. 31, 2023	Jul. 31, 2022
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	$ 385,000
Foreign Currency Forward Contracts | Notional Sell Amounts
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	146,717	$ 168,410
Foreign Currency Forward Contracts | Notional Sell Amounts | Euro
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	95,064	88,275
Foreign Currency Forward Contracts | Notional Sell Amounts | British pound
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	20,489	36,779
Foreign Currency Forward Contracts | Notional Sell Amounts | Mexican Peso
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	3,227
Foreign Currency Forward Contracts | Notional Sell Amounts | Japanese yen
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	23,195	16,688
Foreign Currency Forward Contracts | Notional Sell Amounts | Hong Kong dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	2,080	0
Foreign Currency Forward Contracts | Notional Sell Amounts | Australian dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	0	278
Foreign Currency Forward Contracts | Notional Sell Amounts | Singapore dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	60	378
Foreign Currency Forward Contracts | Notional Sell Amounts | Taiwan Dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	0
Foreign Currency Forward Contracts | Notional Sell Amounts | Others
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	2,602	26,012
Foreign Currency Forward Contracts | Notional Sell Amounts
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	490,020	642,295
Foreign Currency Forward Contracts | Notional Sell Amounts | Euro
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	194,850	333,285
Foreign Currency Forward Contracts | Notional Sell Amounts | British pound
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	132,956	78,942
Foreign Currency Forward Contracts | Notional Sell Amounts | Mexican Peso
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	28,158
Foreign Currency Forward Contracts | Notional Sell Amounts | Japanese yen
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	17,908	37,163
Foreign Currency Forward Contracts | Notional Sell Amounts | Hong Kong dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	7,265	67,341
Foreign Currency Forward Contracts | Notional Sell Amounts | Australian dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	9,236	9,426
Foreign Currency Forward Contracts | Notional Sell Amounts | Singapore dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	19,817	18,025
Foreign Currency Forward Contracts | Notional Sell Amounts | Taiwan Dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	8,000
Foreign Currency Forward Contracts | Notional Sell Amounts | Others
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	$ 71,830	$ 98,113

XML

Derivative financial instruments - Summary of Fair Values Of Net Investment Contracts (Details)	Jul. 31, 2023 USD ($)
Prepaid expenses and other current assets
Investments, All Other Investments [Abstract]
Net investment contracts	$ 2,977,000
Derivative [Line Items]
Net investment contracts	2,977,000
Other assets
Investments, All Other Investments [Abstract]
Net investment contracts	59,000
Derivative [Line Items]
Net investment contracts	59,000
Accrued liabilities
Investments, All Other Investments [Abstract]
Net investment contracts	841,000
Derivative [Line Items]
Net investment contracts	841,000
Other long-term liabilities
Investments, All Other Investments [Abstract]
Net investment contracts	3,760,000
Derivative [Line Items]
Net investment contracts	$ 3,760,000

XML

Long-term debt - Long-Term Debt (Detail) - USD ($)	Jul. 31, 2023	Jun. 06, 2023	Oct. 31, 2022	Apr. 30, 2019
Debt Instrument [Line Items]
Long-term debt	$ 846,286,000		$ 738,822,000
Less current maturities and notes payable	110,643,000		392,537,000
Less unamortized debt issuance costs	8,188,000		965,000
Long-term maturities	727,455,000		345,320,000
Revolving credit facility		$ 1,150,000,000
Senior notes, due 2023-2025
Debt Instrument [Line Items]
Senior notes	$ 32,000,000		55,500,000
Weighted average interest rate for borrowings	3.10%
Senior notes, due 2023-2027
Debt Instrument [Line Items]
Senior notes	$ 54,286,000		71,429,000
Weighted average interest rate for borrowings	3.11%
Senior notes, due 2023-2030
Debt Instrument [Line Items]
Senior notes	$ 260,000,000		350,000,000
Weighted average interest rate for borrowings	3.97%
Euro Loan
Debt Instrument [Line Items]
Term loan due 2026	$ 0		261,893,000
Revolving Credit Facility
Debt Instrument [Line Items]
Weighted average interest rate for borrowings	6.00%
Revolving credit agreement, due 2028 | Maximum
Debt Instrument [Line Items]
Revolver Base Rate Range		0.20%
EuroDollar Base Rate Range		1.20%
Revolving credit agreement, due 2028 | Minimum
Debt Instrument [Line Items]
Revolver Base Rate Range		0.00%
EuroDollar Base Rate Range		0.85%
Revolving credit agreement, due 2028
Debt Instrument [Line Items]
Revolving credit agreement, due 2024	$ 200,000,000		0
Revolving credit facility		$ 1,150,000,000
Revolving Facility Maximum Borrowing Capacity		850,000,000
Revolving credit agreement, due 2024
Debt Instrument [Line Items]
Revolving credit facility				$ 850,000,000
Term Loan Due 2026
Debt Instrument [Line Items]
Term loan due 2026	$ 300,000,000	$ 300,000,000	$ 0

XML

Long-term debt - Additional Information (Detail) € in Thousands	1 Months Ended	9 Months Ended
	Apr. 30, 2019 USD ($)	Jul. 31, 2023 EUR (€)	Jul. 31, 2023 USD ($)	Jun. 06, 2023 USD ($)	Oct. 31, 2022 USD ($)
Debt Instrument [Line Items]
Revolving credit facility				$ 1,150,000,000
Senior notes, due 2023-2025
Debt Instrument [Line Items]
Weighted average interest rate for borrowings		3.10%	3.10%
Remaining weighted average life of notes		1 year 3 months
Senior notes, due 2023-2027
Debt Instrument [Line Items]
Weighted average interest rate for borrowings		3.11%	3.11%
Remaining weighted average life of notes		2 years 2 months 23 days
Senior notes, due 2023-2030
Debt Instrument [Line Items]
Weighted average interest rate for borrowings		3.97%	3.97%
Remaining weighted average life of notes		3 years 1 month 17 days
Euro Loan
Debt Instrument [Line Items]
Term loan due 2026			$ 0		$ 261,893,000
Euro Loan | Euro
Debt Instrument [Line Items]
Euro Loan | €		€ 180,000
Revolving credit agreement, due 2024
Debt Instrument [Line Items]
Revolving credit facility	$ 850,000,000
Credit facility, term	5 years
Revolving credit agreement, due 2024 | Swing Line Loans
Debt Instrument [Line Items]
Revolving credit facility	$ 75,000,000

XML

Contingencies (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Accrual for environmental liability	$ 266	$ 266

XML

Subsequent Events (Details) - EUR (€)

9 Months Ended

Aug. 24, 2023

Jul. 31, 2023

Subsequent Event [Line Items]

Subsequent Events

Subsequent Event

On August 24, 2023, the Company completed the acquisition of the ARAG Group and its subsidiaries (ARAG Group or ARAG) pursuant to the terms of the Sale and Purchase Agreement, dated as of June 25, 2023, by and among the Company, its Italian subsidiary, Capvis Equity V LP (Capvis), DRIP Co-Investment (DRIP), and certain individuals (the Individual Sellers, and together with Capvis and DRIP, collectively, the Sellers). ARAG is a global market and innovation leader in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. ARAG will operate as a division of our Industrial Precision Solutions segment. In anticipation of the acquisition, the Company entered into a €760,000 senior unsecured term loan facility with a group of banks in August 2023 (the Term Facility). The Term Facility has a 364-day term and matures in August 2024, and loans under the facility bear interest at a eurocurrency rate plus an applicable margin that will range from 1.1250% to 1.625% based on the Company’s Leverage Ratio (as defined in the term loan credit agreement and calculated on a consolidated net debt basis). The all-cash ARAG acquisition of approximately €957,000, net of the repayment of approximately €30,300 of debt of the acquired companies, was funded using the Term Facility and Revolving Facility. The financial results of the ARAG Group acquisition are not expected to have a material impact on our Consolidated Financial Statements.

ARAG Group | Subsequent Event

Subsequent Event [Line Items]

All-cash transaction

€ 957,000,000

Term Loan Facility

760,000,000

Debt Repayment of Acquired Company

€ 30,300,000

ARAG Group | Subsequent Event | Minimum

Subsequent Event [Line Items]

Euro Currency Rate

1.125%

ARAG Group | Subsequent Event | Maximum

Subsequent Event [Line Items]

Euro Currency Rate

1.625%